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ABSTRACT 
 
Agrobacterium tumefaciens has long been an important tool for plant genetic 
transformation. Many important crop plants such as maize, soybean, wheat, and rice, as 
well as numerous other dicot plant species are able to be transformed using A. 
tumefaciens. While many potential regulatory RNA have been previously identified in A. 
tumefaciens, very few have been verified with a functional investigation. With the 
growing understanding of regulatory RNA, and its importance in gene regulation, it is 
essential to further classify regulatory RNA in the transformative tool A. tumefaciens. It 
is possible that regulatory RNA could be involved in virulence and their expression 
altered to increase transformation efficiency. 
In this work, a particular candidate regulatory RNA, anti-virC2, was selected and 
investigated. While anti-virC2 was identified previous to this research, the function of 
anti-virC2 has never before been examined. The location of anti-virC2 is on the Ti-
plasmid antisense to the virulence gene virC2 and it was initially hypothesized that anti-
virC2 acted to regulate the virC2 gene in cis.  
Through deletion of the promoter region, expression of the anti-virC2 transcript 
was reduced by ~39% in mutant strain C58 ∆Pavc2. Using this strain, changes in virC2 
transcript and protein abundance were able to be observed and compared to wild type. In 
addition, other possible changes in virulence due to the drop in anti-virC2 expression 
were examined through Kalanchoe daigremontiana tumorigenesis assays and 
Arabidopsis thaliana infection experiments.  
This work shows that anti-virC2 does not act to regulate the cis encoded virC2 
gene but may have some impact on virulence. Additional anti-virC2 targets were also 
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predicted and may be investigated in future studies. As well as the findings made 
regarding anti-virC2, this study provides an example for the functional study of 
additional regulatory RNA and may serve as a model for the investigation of other 
potential regulatory RNAs. 
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CHAPTER I 
GENERAL INTRODUCTION AND LITERATURE REVIEW 
 
1.1 General Introduction 
Since its first implementation, the process of plant genetic transformation has 
become an essential part of agriculture and a necessary component of research. By 
altering a plant’s genes through plant transformation, plants can gain higher yield, acquire 
disease resistance, or allow functional analysis of specific genes.  
One of the most important tools used for plant transformation is Agrobacterium 
tumefaciens. While a plant pest in nature, the natural DNA transferring process by which 
A. tumefaciens infects plants can be harnessed by researchers to transform a variety of 
important plants. The process of DNA transfer from bacteria to plants also provides a 
unique system of interkingdom DNA transfer to study. 
A new frontier of research is that of regulatory RNA. Over the past decade the 
number of identified regulatory RNA identified has been steadily increasing. Regulatory 
RNAs have also been found to play an important role in the regulation of gene 
expression. 
This research is aimed at studying regulatory RNA within A. tumefaciens. 
Specifically, the role of the transcript opposite the virC2 gene was examined. By gaining 
an understanding of this regulatory RNA in A. tumefaciens we can come to better 
understand the general function of regulatory RNA in addition to better understanding A. 
tumefaciens. As understanding of regulatory RNA within A. tumefaciens increases it may 
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be possible to alter expression of these molecules resulting in an improved plant 
transformation frequency. 
 
1.2 Importance of Agrobacterium 
The Agrobacterium genus is made up of a group of gram-negative, soil-borne, 
plant pathogenic bacteria (Chilton et al., 1977). In nature, Agrobacterium is able to infect 
plants by inserting a piece of its DNA (T-DNA) into the plant genome where it then 
incorporates and is expressed in the host (for reviews of this process see Binns and 
Thomashaw, 1988; Zhu et al., 2000; Gelvin. 2010). Once the bacterial DNA has been 
incorporated, the encoded opine genes are expressed, leading to the production of short 
amino acids and sugars the bacteria then utilize (Britton et al., 2008). Formation of a 
tumor, or gall, is caused by expression of oncogenes which result in increased plant 
production of the hormones auxin and cytokinin (Morris et al., 1986). The process of 
plant infection by Agrobacterium is an example of interkingdom DNA transfer and 
provides an interesting phenomenon to study. 
Agrobacterium is particularly important, not only because of the crown gall 
disease it causes in plants, but as a tool for genetic manipulation. By exploiting the 
natural DNA insertion that occurs when A. tumefaciens infects plants, it is possible for 
scientists to insert any DNA sequence into the plant, changing its genetic composition 
(for reviews see Nester, 2014; Ziemienowicz, 2014). 
Within the genus Agrobacterium, organisms are divided into species depending 
on the plants they able to infect and the symptoms produced upon infection. The five 
main species include A. rubi which causes cane gall on raspberries, A. tumefaciens which 
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causes crown gall disease on a wide variety of dicots, A. vitis which infects grapes, A. 
rhizogenes which causes a proliferation of roots resulting in hairy root disease, and A. 
radiobacter which is not infectious (Slater et al., 2009). Recently though, it has been 
proposed that Agrobacterium species should be changed to species within the Rhizobium 
genus, though there is still debate (Mousavi and Österman. 2014). While each species of 
Agrobacterium is important for different reasons, this work will be centered on A. 
tumefaciens. A. tumefaciens is the species most widely used for plant transformation, and 
has a very important role in the genetic transformation of several important commercial 
crops (Gelvin, 2003; Wang, 2006). 
 
1.2.1 Agrobacterium tumefaciens as a natural plant pest 
In nature, A. tumefaciens is found either as a plant pathogen or free-living in the 
rhizosphere (Bouzar and Moore, 1987). Of all known plant pathogens, A. tumefaciens has 
the largest number of host plants, over 600 host plants have been documented (DeCleene 
and DeLay, 1976). Several of these host plants are of economic importance (Escobar and 
Dandekar, 2003). Examples of affected plants include grape (Burr and Otten, 1999), 
stone fruits, nuts (Epstein et, al. 2008; Pulawska, 2010), and many dicotyledonous plants 
(Thomashow, et al. 1980). Crown gall disease can severely damage crops by decreasing 
yield and growth, however, unless infection occurs when the plant is very young, it is 
generally not lethal (Escobar and Dandekar, 2003). On average, plants with crown gall 
tumors are 25% smaller compared to non-infected plants (Tzfira and Citovsky, 2008). 
The impact of crown gall to agriculture can add up to devastating losses. 
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Just as the name implies, the main symptom of crown gall disease is the formation 
of crown gall tumors on the infected area of the plant. The symptoms of crown gall 
disease were first described in 1853 in a French article (Fabre and Dunal, 1853), but the 
cause of crown gall disease was unknown. In 1907, it was realized that Agrobacterium 
tumefaciens was the causal agent of crown gall disease in the Paris daisy by isolating the 
A. tumefaciens bacteria from the galls which were formed on daisies (Smith and 
Townsend, 1907).  
The tumors formed can grow up to be 30 cm and contain their own 
vascularization structures (Tzfira and Citovsky, 2008). The production of crown gall 
tumors is the result of increased levels of the hormones cytokine and auxin, which are 
overproduced in cells that have been transformed by A. tumefaciens during an infection. 
However, not all of the cells in a crown gall tumor have been transformed, only 10-26% 
of cells in a tumor are transformed while the rest of the cells maintain an unaltered 
genotype (Van Slogteren et al., 1983). 
 
1.2.2 Agrobacterium tumefaciens as a tool for plant genetic modification 
Agrobacterium tumefaciens has been very important to modern biotechnology as 
far back as the late 1970’s when scientists began to understand the mechanisms of the 
bacteria’s pathogenesis. As researchers studied A. tumefaciens, they learned that during 
infection, the bacteria transferred a piece of DNA to the plant host. In a groundbreaking 
study, Chilton et al. (1977) were able to use probes specific to various regions of the A. 
tumefaciens genome to probe crown gall tumors and discover that some piece of the 
tumor inducing (Ti) plasmid was transferred to the plant during infection. 
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In later research, scientists defined the exact boundaries of the T-DNA transferred 
to the plant (Zambryski et al., 1982) as a right border and a left border (Joos et al., 1983; 
Wang et al., 1984). 
Once the concept was established that A. tumefaciens is able to transfer a distinct 
portion of its DNA to be incorporated into the plant genome, scientists began to take 
advantage of this mechanism to transfer other DNA sequences. In a pioneering study by 
Zambryski et al. (1983), researchers were able to create a “disarmed” version of the 
tumor inducing (Ti) plasmid by removing the tumor causing genes and only leaving the 
left and right border sequences flanking a nopaline synthase gene used to detect the DNA 
once it was transferred to the plant. This experiment was the first time that plants had 
been transformed with an altered T-DNA and is one of many studies that have led to the 
modern day process of plant transformation using Agrobacterium to deliver DNA. 
Today, using Agrobacterium is used to transform many of the world’s most 
important crops including wheat (Hu, et al. 2003), corn (Frame, et al. 2002), soybean 
(Trick and Finer, 1998), rice (Hiei, et al. 1997), tomato (Arshad, et al. 2014), as well as 
many other commercial and ornamental plants (Wang, 2006; Wang, 2015).  
 
1.3 The Process of Plant Transformation by Agrobacterium tumefaciens 
In order to fully understand the important role of A. tumefaciens as a plant pest 
and genetic engineer, it is vital to understand the biological mechanisms involved with 
the infection process. While there are many genes involved with this process, the 
virulence, (vir) genes, located on the Ti plasmid, are the most essential. 
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1.3.1 Genomics of Agrobacterium tumefaciens 
The genome of A. tumefaciens is composed of four replicons (Goodner et al., 
2001; Wood et al., 2001). First there are the two chromosomes, linear and circular 
chromosomes are 2,075,560 bp and 2,841,490 bp in size, respectively (Wood et al., 
2001). These two chromosomes encode all of the genes necessary for the survival of the 
organism and are always present in A. tumefaciens. The remaining two replicons are 
plasmids that may or may not be present, named the At plasmid and the Ti plasmid.  
Originally termed the “cryptic plasmid”, the At plasmid has the less important 
role of the two accessory plasmids. Encoded on this 542,779 bp plasmid are genes 
important for the metabolism of certain nutrients as well as attachment (Goodner et al., 
2001; Baek et al., 2005; Chai et al., 2007). When measuring virulence using qualitative 
tumorigenesis assays, no effect on virulence was observed upon deletion of the At 
plasmid (Hooykaas et al., 1977; Rosenberg and Huguet, 1984; Hynes et al., 1985). A 
more recent study observed a decline in pathogenic virulence upon deletion of the At 
plasmid by using a qualitative measurement of virulence gene induction (Nair et al., 
2003). However, it remained clear that deletion of the At plasmid did not cause total loss 
of virulence. 
The Ti plasmid is the other accessory plasmid that may be present in A. 
tumefaciens. Primarily responsible for plant infection and tumor induction (Wood et al., 
2001), the Ti plasmid is 214,233 bp in size and contains nearly all of the genes important 
for pathogenic virulence (Wood et al., 2001). The six operons crucial for virulence are 
virA, virB, virC, virD, virE, and, virG each of which encodes genes with important roles 
in the plant infection process (Goodner et al., 2001).   
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1.3.2 Regulation 
Regulation of the virulence system is controlled by the VirA/VirG two-
component sensor kinase system, which is able to sense phenolic compounds, often 
produced by wounded plants (Winans et al., 1986, Winans et al., 1994; Lin et al., 2014). 
Upon sensing these compounds, VirA is able to activate itself through 
autophosphorylation and subsequently phosphorylate and activate VirG (Jin et al., 1990a; 
Jin et al., 1990b). VirG then activates expression the of rest of the virulence genes by 
binding to the vir-box region located in their promoter region (Jin et al., 1990c).  
Located on the circular chromosome, the chromosomal virulence (chv) genes, are 
also involved with regulation of the virulence system (Suzuki et al., 2002). ChvE is able 
to extend the range of phenolic compounds and sugars detectable by A. tumefaciens. 
ChvE senses compounds not easily detected by VirA and leads to VirA’s activation 
(Peng et al., 1998).  
In addition to sensing phenolics and sugars, A. tumefaciens is able to sense acidic 
environmental conditions which are often produced by plants and given off into the soil 
(Rivoal and Hanson, 1994; Walker et al., 2003; Wang et al., 2006). pH is perceived by 
the ChvI/ChvG two component system (Mantis and Winans, 1993; Li et al., 2002), which 
is similar to the VirA/VirG two component system. ChvG detects acidic signals leading 
to activation of the response-regulator ChvI and downstream activation of VirG and the 
VirB proteins (Charles and Nester, 1993; Mantis and Winans, 1993; Li et al., 2002). 
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1.3.3 T-DNA transfer and integration 
The activated virulence system then needs to prepare the T-DNA for transfer to 
the plant. There are several proteins that play a role in this process.  
Excising the T-DNA from the Ti plasmid is the first step in preparing the T-DNA 
to be transferred to the plant host. First, VirD2, along with VirD1, acts to nick the lower 
strand of the right and left border sequences that directly flank the T-DNA region 
(Yanofsky et al., 1986; Jayaswal et al., 1987; Porter et al., 1987; Wang et al., 1990), 
resulting in a single stranded T-DNA molecule (Satchel and Nester, 1986). VirC1 and 
VirC2 aid in this process by binding to a region near the right border called “overdrive,” 
though it remains unclear exactly how these proteins function (Lu et al., 2009). 
VirD2 binds to the 5’ end of the T-strand in the bacteria and remains attached 
during transfer to the plant (Herrera-Estrella et al., 1990; Rossi et al., 1993; Herrera-
Estrella et al., 1998). VirE2 is also part of this complex, and acts to coat the T-strand in 
the plant to prevent degradation of the T-strand (Christie et al., 1988; Citovsky et al., 
1989; Sen et al., 1989).  
A. tumefaciens uses a Type IV secretion system to transfer the T-strand to the 
plant cell (Christie et al., 1997). The type IV secretion system is composed of the 11 VirB 
proteins and the VirD4 protein (Ward et al., 2002; Christie et al., 2004), each with a 
distinctive role. VirD4 directs the T-strand into the secretion channel formed by VirB7, 
VirB9, and VirB10 (Fronzes et al., 2009), while VirB4 helps to move the complex 
forward (Berger and Christie, 1993; Kumar and Anath, 2002; Atmakuri et al., 2004). The 
pilus used to secrete the T-DNA to the plant is composed of VirB2 and VirB5 (Yuan et 
al., 2005). A simplified graphical representation of this process can be seen in Figure 1. 
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Once the T-strand complex is inside the plant, the DNA must then integrate with 
the host genome. Both VirE2 and VirD2 contain nuclear localization signals which guide 
the T-DNA to the host nucleus (Citovsky et al., 1992; Howard et al., 1992; Rossi et al., 
1993; Citovsky et al., 1994). Though integration was originally thought to take place at 
random locations in the genome, several large studies have found correlations between 
the site of T-DNA integration and gene locations in the host plant (Brunaud et al., 2002; 
Alonso et al., 2003). Yet in another study, when T-DNA insertion locations were 
examined without selection pressure, integration was found to occur in a more random 
distribution (Kim and Gelvin, 2007).  
Once the T-DNA is incorporated in the plant genome it may be expressed stably, 
transiently, or become silenced depending on the location of insertion and histone or 
DNA methylation levels. (Matzke et al., 1989; Janssen and Gardner, 1990; Gohlke et al., 
2013) The number of insertion events has also been shown to affect gene expression, 
(Hobbs et al., 1990; Van Der Krol et al., 1990). Genes integrated into the plant’s genome 
may also be passed down to subsequent generations where the genes can continue to be 
expressed (Budar et al., 1986), but the pattern of inheritance depends on the gene, plant 
variety, and the number of insertion events in the plant genome (Yin et al., 2003; Xi et 
al., 2009). 
 
1.4 Importance of the virC Operon 
 
1.4.1 The host range determinant 
The genes contained on the virC were operon first characterized and described as 
a “host range determinant” during the early 1980’s, but have proven to be an important 
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part of the process of Agrobacterium mediated plant transformation (Klee et al., 1983; Lu 
et al., 2009). 
Like all other vir genes of A. tumefaciens, the virC operon is housed on the Ti 
plasmid, specifically located between the virG and virD operons (Figure 2). However, the 
virC operon is different than all other vir genes, it is located on the opposing DNA strand 
(Figure 2). This specific positioning seems to be conserved among Agrobacterium 
strains. When examining nopaline and octopine type Ti plasmids, both have the virC 
operon located on the DNA strand opposite to the other virulence genes (Close et al., 
1987; Yanofsky et al., 1985; Komari et al., 1986). Though the alternate strand placement 
is curious, whether it provides any significant advantage to the organism’s fitness 
remains to be discovered. 
The virC operon contains two open reading frames, 696 and 609 nucleotides in 
length, coding for the VirC1 and VirC2 proteins, respectively (Close et al., 1987). Often 
referred to as “host range determinants,” the loss of either virC1 or virC2 leads to a range 
of phenotypes from a mild reduction in virulence to full avirulence depending on the host 
plant infected (Yanofsky et al., 1985; Yanofsky and Nester, 1986). 
Specifically, in 1983, it was observed that both virC1 and virC2 loss of function 
mutants produced a severely attenuated phenotype on Vinca rosea (periwinkle) and 
Kalanchoe daigremontiana. Yet when these strains were used to infect other plants such 
as Datura stramonium (jimsonweed) and Nicotiana tabacum cv. Havana (tobacco), a 
milder attenuation of virulence was observed (Close et al., 1983).  
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1.4.2 Function of virC1 and virC2  
It is clear that the loss of either virC1 and or virC2 causes attenuation to a varying 
degree, but what are the mechanisms behind this phenomenon? The first clue to the 
function of these proteins comes from a study by Horsch et al. (1986). For this research, a 
system was developed to compare rates of T-DNA transfer from a binary vector and from 
the native Ti plasmid to leaf discs of Petunia hybrida. It was possible to determine the 
source of the DNA transferred to the leaf discs based on specific markers in the DNA. 
The system was used to examine rates of T-DNA transfer from several vir gene 
loss of function mutants caused by transposon insertion. For most mutant strains tested, 
rates of T-DNA transfer uniformly declined from both the Ti plasmid and the binary 
vector when compared to wild type. However, in virC1 and virC2 loss of function 
mutants, it was observed that while rates of T-DNA transfer from the binary vector and 
Ti plasmid both declined, T-DNA was transferred much more frequently from the binary 
vector than the Ti plasmid (Horsch et al., 1986). 
 The researchers speculated this may occur because the binary vector could act 
like a natural intermediate formed by the T-DNA during the normal transfer process. The 
results suggested virC1 and virC2 were essential to these early T-DNA processing 
reactions needed to form an intermediate structure that was not necessary when T-DNA 
was being transferred from the binary vector (Horsch et al., 1986).  
In order to better understand the function of the VirC proteins it is also important 
to understand the overdrive sequence located on the Ti plasmid, adjacent to the right 
border (Peralta et al., 1987; van Harren et al., 1987). The overdrive sequence has been 
shown necessary for full virulence by playing a role in T-DNA transfer efficiency and 
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possibly in the formation of an intermediate structure (van Harren et al., 1987; Toro et al., 
1988). Both VirC1 and VirC2 have been shown to bind the overdrive region through 
affinity chromatography, supporting the idea that these proteins play a role in early T-
DNA processing (Toro et al., 1988).  
In 2007 a deeper look at the function of the VirC proteins was taken (Atmakuri et 
al., 2007). First, researchers examined the effects of the VirC proteins on T-strand 
production, finding that when VirC1, VirC2, or both were non-functional, the number of 
T-strand molecules generated in the A. tumefaciens cell was reduced by three- to four-
fold. The ability of the VirC1 and VirC2 proteins to bind DNA on the Ti plasmid was 
demonstrated through co-immunoprecipitation assays. Additionally, VirC1 and VirC2 
were reported to work together in early T-DNA processing reactions. Without the 
presence of VirC2, VirC1 antibodies precipitated fewer copies of the Ti plasmid 
compared to the wild-type strain. Also, through the use of co-immunoprecipitation 
assays, researchers were able to show interactions between VirC1 and VirC2. VirC1 was 
also shown to interact with VirD1, VirD2, and VirD4, other proteins known to be 
involved in the reactions of early T-DNA formation. Combined, the results suggest VirC1 
and VirC2 work together and along with the VirD proteins, stimulate reactions occuring 
early in the process of T-DNA formation (Atmakuri et al., 2007).  
A more recent report from Lu et al. (2009) details the crystal structure and 
molecular function of the VirC2 protein. A crystal structure was developed depicting the 
stable C-terminal end of the VirC2 protein from amino acids 82-202. From this crystal 
structure, researchers were able to detect structural homology between VirC2 and the 
superfamily of Arc/MetJ repressors (Lu et al., 2009). An important similarity between 
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VirC2 and this group of repressors is the ribbon-helix-helix (RHH) domain usually used 
by bacterial proteins to bind DNA (Schreiter and Drennan, 2007). By analyzing VirC2’s 
crystal structure, researchers were able to find a B-strand-helix-helix motif closely 
resembling the RHH domain found in Arc/MetJ repressors (Lu et al., 2009).  
In the superfamily of Arc/MetJ repressors, two proteins, each containing one 
RHH domain, work in a dimeric fashion to bind DNA. The VirC2 protein uses two RHH 
domains within the same protein for DNA binding (Schreiter and Drennan, 2007; Lu et 
al., 2009).  
Lu et al. (2009) examined the ability of VirC2 to bind DNA. Because VirC2 had 
been shown to bind the overdrive region in the past, researchers used electrophoretic 
mobility shift assays (EMSAs) to determine VirC2’s binding affinity for three different 
20 bp regions of double-stranded DNA adjacent to the right border sequence. One of the 
regions contained the overdrive core sequence. It was observed that full-length VirC2 
was able to bind each region of DNA with a higher binding affinity for the DNA segment 
containing the overdrive sequence. VirC2 was also observed to bind an unrelated 20 bp 
DNA sequence (used as a control) suggesting a high level of unspecific binding to double 
stranded DNA. VirC2 was not shown to bind any single-stranded DNA targets (Lu et al., 
2009). 
To examine the importance of individual amino acids’ role in the DNA-binding 
process, Lu et al. (2009) generated several mutants containing a missense mutation. 
These mutants were then assayed for their ability to bind DNA through EMSAs and for 
virulence by Nicotiana glauca and Kalanchoe daigremontiana tumorigenesis assays. In 
several of the strains with an altered amino acid located on the surface of the protein 
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(hypothesized to be involved in DNA binding) a lower binding affinity for DNA and a 
reduction in virulence was observed, suggesting those particular amino acids were 
important for DNA binding. By demonstrating the ability of the VirC2 protein to bind to 
the overdrive region and showing its important for full virulence, Lu et al. (2009) 
provides further support of hypothesis that VirC2 contributes to early T-DNA formation 
through its interaction with the overdrive region. 
Although research has shown that VirC proteins bind the overdrive region, 
facilitate early T-DNA processing reactions, and play an important role in virulence, 
there remain new discoveries to be made. In order to further explore the virC operon, a 
closer look at the world of regulatory RNA must be taken. 
 
1.5 Non-coding Regulatory RNA 
 
1.5.1 Growing importance of regulatory RNA across life 
Regulatory RNAs have been found to be present in every domain of life and often 
play a role in complex regulatory processes (Gottesman and Storz., 2011; Marchfelder et 
al., 2012; Barrett et al., 2012). Because A. tumefaciens is such an important organism for 
biotechnology and genetic engineering, it is important to investigate the possible 
importance of regulatory RNAs on the biology of A. tumefaciens. In addition, elucidation 
of novel regulatory RNAs may allow new methods to be developed to modify A. 
tumefaciens thereby improving the efficiency of plant transformation. 
Researchers have long known that RNA has the ability to perform complex 
functions. Some researchers even hypothesize in the RNA World Theory that at one time, 
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RNA not only acted as a messenger between DNA and proteins, but also, performed 
information storage and catalytic functions (Higgs and Lehman, 2015).  
The early role of RNA (instead of DNA) was first identified in the 1960’s when 
researchers realized an all RNA world would be a less complex forerunner to the current 
model using DNA, RNA, and protein (Crick, 1968; Orgel, 1968). In later years, 
researchers observed ribonucleotide structures able to act as coenzymes with proteins, 
further confirming RNA’s ability to perform catalytic functions, and suggesting current 
coenzyme activity maybe a remnant from the RNA world (White, 1976). However, in the 
1960’s and 70’s RNA was still considered to act mainly as a template between DNA and 
proteins in modern organisms, or in the case of tRNA and rRNA, serve as a structural 
feature for the construction of proteins (Hoagland et al., 1958; Brenner et al., 1961). 
The idea of RNA acting as a regulatory molecule in modern organisms was first 
proposed by Britten and Davidson in 1969 after taking notice of a discovery previously 
reported years earlier of a diverse population of heterogeneous nuclear RNA (hnRNA) 
existing in the nucleus (Warner et al., 1966). The observation of a complex pool of RNA 
led researchers to propose a model in which RNA acts in a network to regulate processes 
within the cell (Britton and Davidson, 1969; Britton and Davidson, 1971). However, this 
hypothesis was short lived as researchers focused on other ideas. 
Researchers were eventually led back to the subject in 1993 when a lab studying 
Caenorhabditis elegan development began taking a closer look at mutants which 
displayed extra larval molts and exhibited early cell fates at later, inappropriate times in 
development (Lee, et al. 1993). Researchers already knew these abnormal phenotypes 
were the cause of a mutation in the lin-4 gene (Chalfie et al., 1981). As research 
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progressed on the lin-4 gene, evidence showed lin-4 coded for an RNA able to regulate 
target genes by binding their mRNAs at regions of sequence complementarity (Lee et al., 
1993). Later, this type of regulatory RNA would become known as microRNA (miRNA) 
(Lagor-Quintana et al., 2001; Lau et al., 2001; Lee and Ambros, 2001). 
Using techniques such as size selection and targeted cloning, many additional 
miRNAs were soon discovered in both plant and animal cells (Lagos-Quintana et al., 
2001; Lau et al., 2001; Lee and Ambros, 2001; Reinhart et al., 2002). Another similar 
class of regulatory RNA named small interfering RNA (siRNA) soon emerged (Timmons 
and Fire, 1998; Wianny and Zernicka-Gotez, 2000; Xia. et al, 2002). SiRNA along with 
miRNA make up the two main classes of regulatory RNA present in eukaryotic cells 
(Filipowicz et al., 2005; Carthew and Sontheimer, 2009).  
miRNAs transcripts originate from a variety of regions within a eukaryote’s 
genome and may be found independently, in clusters, or within introns (Bartel, 2004). 
Once a miRNA is transcribed, excess nucleotides on both the 5’ and 3’ ends are trimmed 
and then the miRNA is folded into a stem loop structure (Bartel, 2004). This processing 
step is primarily performed by the Dcl1 protein in plants, while Dicer and Drosha 
perform these functions in animal cells (Kim, 2005). After processing, one strand of the 
miRNA duplex structure then associates with the Ago protein along with additional 
proteins to form the miRNA-induced silencing complex (miRISC) and the other strand is 
lost (Bartel, 2004; Kim, 2005). The miRISC complex is then able to recognize mRNAs 
which have complementary to the miRNA and cause translational repression or mRNA 
cleavage (Wu et al., 2006; Cathew and Sontheimer, 2009).  
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siRNAs function in a similar manner to miRNA, although there are some notable 
differences. While miRNAs originate from the organism’s own genome, siRNA usually 
originate from cleavage of long double stranded RNA (dsRNA) that comes from outside 
the cell (Mello and Conte, 2004). siRNA can originate in nature when the plant cell 
detects viral dsRNA and processes the dsRNA into siRNA for defense, but may also be 
used by researchers to induce silencing of desired genes (Fire et al., 1998; Hannon, 2004; 
Mlotshwa et al., 2008). When dsRNA enters the cell it is first cleaved by Dicer into 21-24 
bp long siRNA (Bernstein et al., 2001; Ketting et al., 2001). Like miRNAs, one strand of 
the siRNA duplex along with proteins including Ago, form the siRISC complex while the 
other strand is lost (Liu et al., 2006). The siRISC is then able to cleave RNA strands with 
sequence homology to the siRNA (Tomari et al., 2007; Wilson and Doudna, 2013).  
While siRNA and miRNA are the most well studied small RNA (sRNA) in 
eukaryotic cells there are several additional classes of RNAs important for gene 
regulation. Long non-coding RNA (lncRNA) are a class of regulatory RNA that can be 
easily differentiated by their length. Usually lncRNA are longer than 200nt and do not 
code for proteins (Morris and Mattick, 2014). For many lncRNA there is no evidence of 
functionality, yet for other species there are clues suggesting they may serve a purpose 
(Morris and Mattick, 2014). For example, some lncRNA are differentially expressed 
depending on tissue and cell type (Mercer et al., 2008; Moràn et al., 2012).  Another class 
of regulatory RNA are piwi-interacting RNAs (piRNA) which are involved with key 
epigenetic modifications to the chromatin of germ line cells (Bamezai et al., 2012). 
Circular RNAs (circRNAs) are a recently discovered class of regulatory RNA in animal 
cells which form a closed loop structure and regulate gene expression in a post-
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transcriptional manner (Memczak, et al. 2013). With the research that has already been 
completed, it is clear that regulatory RNA are an important part of gene regulation. In the 
coming years, as research in the field progresses, additional classes and functions of 
regulatory RNA will continue to be discovered. 
 
1.5.2 Non-coding regulatory RNA in bacteria 
Non-coding RNA is also important for gene regulation in prokaryotic cells, 
though the regulatory mechanisms are somewhat different. Specifically, in bacteria there 
are two main classes of regulatory RNA, riboswitches and sRNA (Waters and Storz. 
2009). Riboswitches are portions of mRNA which are able to detect and respond to 
metabolites or other environmental cues. Riboswitches respond by causing a change in 
mRNA conformation, decreasing translation and/or stability, resulting in a change in 
gene expression. However, because riboswitches exist as part of an mRNA, riboswitches 
are not non-coding regulatory RNA. In this introduction I will focus my attention on 
sRNA; which unlike riboswitches, bind and alter expression of mRNA and usually have 
no translational function on their own. 
Contrary to their name, sRNA range in size from 50 to 300 bp in length (Storz et 
al., 2011), notably different from the miRNA and siRNA regulators in eukaryotic cells 
that average 20-25 bp (Starega-Roslin et al., 2011). sRNA regulators are able to target 
specific mRNA through base pairing, resulting in modified gene expression (Repiola and 
Dafreuille, 2009). In some cases sRNA are also able to bind and regulate proteins (Suzuki 
et al., 2006; Babitzke and Romeo, 2007).  
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sRNA may be located anywhere in the genome relative to their target mRNAs. 
When a sRNA is transcribed from the non-coding DNA strand directly opposite its target 
mRNA it is said to be a cis-acting sRNA; if the sRNA is located elsewhere, it is said to be 
a trans-acting sRNA (Waters and Storz, 2009). Both cis-acting and trans-acting sRNAs 
are able to form secondary stem loop structures and base pair with target mRNA 
sequences, similar to the miRNA mechanism of action in eukaryotic cells (Mahmood et 
al., 2008; Beisel and Storz, 2010). While cis-acting sRNA are usually able to directly 
basepair with target mRNAs, trans-acting sRNA sometimes require the RNA chaperone 
protein Hfq to facilitate binding between the sRNA and target mRNA (Vogel and Luisi, 
2011). The nucleotides on the exposed portion of trans-acting RNA are critical for 
determining if interaction will occur between a sRNA-mRNA pair. This region is named 
the seed sequence (Brantl, 2007). The correct seed sequence along with facilitation by 
Hfq allows trans-acting sRNA to regulate mRNA that do not have complementary 
sequences (Kawamoto, et al. 2006). In fact, most trans-acting sRNA usually act to 
regulate more than one target mRNA (Papenfort and Vogel, 2009). 
Binding of a target mRNA by a sRNA usually results in a negative regulation of 
the mRNA, though in some cases the mRNA may be positively regulated (For detailed 
reviews see Waters and Storz, 2009; Kang et al., 2014). Most commonly, the sRNA will 
bind to the mRNA and cover the ribosome binding site, leading to a decrease in 
translation (De Lay et al., 2013). Binding of the sRNA to the mRNA can also lead to 
degradation of the complex which can occur separately or along with translational 
repression (Waters and Storz, 2009). In order to positively regulate a target mRNA, 
sRNAs cause a change in mRNA conformation through binding, making the ribosomal 
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binding site more accessible, and/or giving rise to a stabilizing effect (Waters and Storz, 
2009; Soper et al., 2010). 
There are several reasons why using sRNA for regulation is advantageous to 
bacteria. First, bacteria often need to quickly regulate genes in response to rapidly 
fluctuating environments. sRNA are able to be both synthesized and degraded more 
quickly than protein, making regulatory RNA ideal when a quick response is needed 
(Shimoni, et al. 2007). Secondly, producing a sRNA requires fewer resources when 
compared to protein production. During protein synthesis there is the additional step of 
translation, while sRNA synthesis is able to be stopped after transcription. Also, sRNAs 
can provide an additional level of regulation alongside transcription factors and other 
proteins, leading to a greater fine tuning of biological responses (Levine et al., 2007; 
Mehta et al., 2008).  
There are many examples in the literature in which bacteria utilize sRNA to 
regulate various biological processes. For example, in E. coli, a recent review estimated 
between 80 and 100 sRNA are present with roles in many processes including oxidative 
stress tolerance, iron regulation, sugar metabolism, and cell division (Gottesman, 2004; 
Gottesman and Storz, 2011)  
Other well-known examples of regulatory RNA in bacteria include the sRNA Qrr 
which is involved in the quorum sensing system of Vibrio cholerae (Lenz et al., 2004; 
Hammer and Bassler 2007). When cell density is low, four Qrr sRNAs are expressed 
which, along with Hfq, bind the hapR mRNA causing destabilization and a low level of 
HapR protein (Hammer and Bassler, 2007). HapR is a master regulator of quorum 
sensing and normally acts to repress genes associated with biofilm production and 
21 
 
bacterial colonization, while at the same time activating the gene coding for the hap 
protease (Jobling and Holmes 1997; Hammer and Bassler, 2003; Zhu and Mekalanos, 
2003). When HapR is downregulated, repression targets of HapR are then allowed to be 
expressed, while genes which are normally activated by HapR are not transcribed (Ng 
and Bassler 2009). In summary, by acting on HapR the four Qrr sRNAs are able to 
regulate the quorum sensing system in Vibrio cholerae. 
Another example of a well-studied sRNA comes from the bacteria this work is 
centered on, A. tumefaciens. During the process of infection, plants produce γ-
aminobutyric acid (GABA) in wounded tissues as a stress response mechanism 
(Kinnersley et al., 2000). GABA is then transported into the bacterial cell through an 
ABC transporter where it disrupts quorum signaling by degradation of the quorum signal, 
homoserine lactone (Wilms et al., 2011). In a recent study, it was shown that A. 
tumefaciens possesses a sRNA, AbcR1, which functions by downregulating Atu2422, a 
periplasmic binding protein essential to the process of GABA uptake, by binding and 
covering the shine delgarno sequence (Wilms et al., 2011). The group went on to 
hypothesize that because this sRNA is able to block uptake of GABA, it is acting to 
preserve bacterial quorum sensing in the presence of plant defense mechanisms (Wilms et 
al., 2011).  
These examples demonstrate a few of the diverse ways bacteria are able to utilize 
sRNA for gene regulation. As the topic continues to be studied, additional processes 
involving sRNA will come to light. However, when studying sRNA in bacteria there are 
many challenges that arise. One of  
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Using the sequences of mRNA and sRNA matched for complementarity is not 
enough to predict interaction since base pairing is most often imperfect and could occur 
at various regions within the transcript. Improving the accuracy of predicting interactions 
is being tackled most effectively through bioinformatics. There are several programs that 
are able to predict mRNA targets given bacterial sRNA sequences. These include 
CopraRNA, IntaRNA, and TargetRNA1 and 2, along with others (Busch et al., 2008; 
Tjaden, 2008; Wright et al., 2013; Kery et al., 2014). In a recent review paper, 
researchers detailed different ways these programs were able to predict targets (Pain et 
al., 2015). Some programs which the group calls “alignment like” search for targets based 
on sequence complementarity (Pain et al., 2015). Other programs consider the 
thermodynamics of interactions between specific RNAs and are called “inter-RNA” 
while another class called “independent fold” uses the way an RNA folds and makes a 
secondary structure to predict the energy for the two transcripts to bind (Pain et al., 
2015). In the same review researchers go on to evaluate various programs using known 
sRNA/mRNA pairs in E. coli. They find that while programs that predict short regions of 
pairing instead of pairing based on the entire transcript more accurately predict 
interactions, though there are still some targets that remain difficult to predict regardless 
of the program. Overall, CopraRNA most accurately identified real targets but was only 
able to do so for organisms with genomes already in the software. The program also 
requires the user to input several homologous sRNAs. The researchers found that 
IntaRNA, RNAplex and RNAup were able to perform well and could be used under 
circumstances when CopraRNA is unavailable (Pain et al., 2015).  
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While there remain many challenges in the study of sRNA in bacteria, research is 
crucial to the full understanding of bacterial gene regulation. As time goes on and 
research progresses there will undoubtedly be more sRNA uncovered.  
 
1.5.3 Non-coding regulatory RNA in Agrobacterium tumefaciens 
In A. tumefaciens, there is a growing understanding of the function and 
importance of regulatory RNA. Recently, researchers in three independent studies used 
RNA-seq in attempts to identify non-coding regulatory RNA in A. tumefaciens. Between 
the three studies, there were a total of 1560 different transcripts identified as potential 
regulatory RNAs (Wilms et al., 2012; Lee et al., 2013; Dequivre et al., 2015)  
There has also been further investigation into the function of several of these 
regulatory RNAs. As described previously, the sRNA AbcR1 plays a role in regulating 
GABA uptake and the preservation of quorum sensing by regulating atu2422 (Wilms et 
al., 2011). Another sRNA that has been characterized in greater detail is repE. Located on 
the Ti plasmid, repE is involved with the Ti plasmid’s replication (Cho and Winans, 
2005) The genes repA, repB, and repC make up the repABC operon and are essential for 
replication of the Ti plasmid (Tabata et al., 1989). Located inside the intergenic region 
between repB and repC is the sRNA repE (Cho and Winans, 2005). When expressed, it 
acts to block replication of the Ti plamid by preventing the translation of repC mRNA 
(Cho and Winans, 2005).  
Another sRNA, rna1111, was shown to play a role in virulence by targeting the 
genes, including traA, involved in bacterial virulence (Dequivre et al., 2015). 
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Though these examples show how sRNA can be characterized, the process often 
remains a challenge. Currently only a small portion of known sRNAs are fully 
characterized. This gap in knowledge exists as an area in research where much still needs 
to be learned. 
 
1.6 Research Objectives and Thesis Organization 
 
1.6.1 Research objectives 
This research began with the goal of identifying and characterizing a sRNA in A. 
tumefaciens. Prior to my joining the lab, experiments to identify potential sRNA had 
already taken place. A paper previously published (Lee et al., 2013) details the 
identification of 475 candidate noncoding RNAs from the genome of A. tumefaciens 
strain C58 after growth under a variety of conditions prior to RNA isolation and 
sequencing.  
Lee et al. (2013) found candidate non-coding RNAs on every replicon in the A. 
tumefaciens genome. With a large number of non-coding RNA candidates identified, the 
next step is to validate and characterize these transcripts. Because Agrobacterium plays 
such an important role in plant transformation the investigation of how sRNAs affect 
virulence is especially important. It became my research goal to verify and characterize a 
sRNA involved with pathogenic virulence. Such a sRNA may also play a role in plant 
transformation. 
The logical place to begin the search for a sRNA involved in virulence was on the 
Ti plasmid. By looking at RNAseq data it became clear that the virC2 antisense strand 
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may encode a cis-acting sRNA; this is evident from the high amount of antisense 
transcript expression. This sRNA was also previously identified in a similar study 
characterizing non-coding regulatory RNA in 2012 and named Ti4 by that group (Wilms 
et al., 2012). There are several reasons to study this candidate sRNA further. First, it is 
expressed in cis, opposite virC2. While sRNA expressed in trans regulate targets located 
elsewhere in the genome, which may be difficult to find, sRNA expressed in cis regulate 
targets on the opposite strand. Second, this sRNA has the potential to be involved with 
bacterial virulence because virC2 plays an important role in the excision of T-DNA from 
the Ti plasmid.  
Another interesting phenomenon to be noted is the difference in expression 
between the virC2 and virC1 transcripts, which are part of the same operon. Usually 
genes transcribed from the same operon have a similar level of expression with a slight 
reduction in expression as the distance from the start site increases and transcription 
machinery pauses or prematurely stops (Lengeler et al., 1999). Here we are able to see a 
dramatic difference between the transcript expression of virC1 and virC2. Might the anti-
sense RNA opposite virC2 be somehow influencing the expression of the virC2 sense 
transcript? 
The goals of this research were to explore the role of the anti-virC2 transcript as 
well as that of the virC2 gene through generation of several mutant strains of A. 
tumefaciens. The mutants were then examined for changes in gene expression, protein 
expression, and virulence. A variety of experiments were used to accomplish this 
including qRT-PCR, tumorgenesis assays using Kalanchoe daigromontiana, and Western 
blot analysis. Agrobacterium-mediated enhanced seedling transformation (AGROBEST) 
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is a technique previously described in which A. tumefaciens is used to transiently infect 
Arabidopsis thaliana seedlings (Wu et al. 2014). AGROBEST was also used in this 
research to compare the ability of A. tumefaciens strains to cause transient GUS 
expression in Arabidopsis thaliana seedlings. 
 
1.6.2 Thesis organization 
This thesis is organized into four chapters. Chapter I consists of a general 
introduction, literature review, and an overview of the organization of this thesis. Chapter 
II presents materials and methods used in this research. Presented in Chapter III are the 
results while Chapter IV presents general conclusions of this work. 
My Major Professor and mentor, Dr. Kan Wang, along with an additional mentor 
in the lab, Dr. Keunsub Lee, have provided me with advice and guidance along every step 
of this project. The work for these projects was carried out by myself and Dr. Keunsub 
Lee. Specifically, Rapid Amplification of cDNA Ends (RACE) experiments and qRT-
PCR experiments were done primarily by Dr. Keunsub Lee with assistance from myself. 
Additional assistance was received from others in the lab to optimize protein extraction 
and RNA isolation including Dr. Keunsub Lee, Dr. Jen Raji and Dr. Evangelia Vamvaka. 
Assistance for GUS quantification was provided by Dr. Dangping Luo from Dr. Yang’s 
lab at Iowa State. My committee, Dr. Allen Miller and Dr. Gwyn Beattie, along with Dr. 
Kan Wang also provided me with ideas and suggestions to improve this project. Without 
help from these individuals this work would not have been possible. 
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Figure 1. The T-DNA transfer process. (Figure directly from Pitzschke and Hirt, 
(2010) Figure 1). Illustration of the plant transformation process by Agrobacterium 
tumefaciens. The T-strand is cleaved from the Ti plasmid and integrated into the plant 
genome where it may be expressed. 
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Figure 2. Illustration of virulence genes on Ti plasmid in A. tumefaciens. (Figure 
directly from Cho and Winans. (2005) Figure 1). Graphic shows the arrangement of 
virulence genes on Ti plasmid from both A) nopaline and B) octopine type Ti plasmids. 
VirC operons are highlighted with the addition of a blue box. Red bars represent protein 
coding genes, while black bars represent IS elements, and gray bars represent 
uncharacterized proteins. 
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CHAPTER II 
MATERIALS AND METHODS 
 
2.1 Bacterial Strains and Plasmids 
 
2.1.1 General cloning procedures 
 
2.1.1.1 Extraction of total DNA from A. tumefaciens 
Bacterial strain C58 from the Wang lab collection was used in all experiments 
unless otherwise specified. Bacteria were streaked from glycerol stock on fresh YEP 
plates (5 g/L yeast extract, 10 g/L peptone, 5 g/L NaCl 12 g/L bacto-agar if solid and the 
pH adjusted to 6.8 with NaOH) (Wang, 2006) and grown for two days at 28 °C. Bacterial 
colonies were transferred to YEP liquid medium and grown overnight, for approximately 
20 hours, shaking at 28 °C at 250 rpm. Bacterial cultures were then centrifuged at 5000 x 
g for 10 minutes at room temperature (25 °C) and the supernatant was removed. DNA 
was then extracted following the standard protocol with buffers and solutions from the 
Qiagen DNeasy Blood and Tissue Kit for gram-negative bacteria (Qiagen Inc., Valencia, 
CA).  Cells were resuspended in 180 μL buffer ATL with the addition of 20 μL 
proteinase K. Samples were vortexed and incubated at 56 °C until lysed. Then 200 μL of 
buffer AL was added and samples were vortexed prior to the addition of 20 μL of 100% 
ethanol. Samples were transferred to the DNeasy mini spin column and centrifuged at 
6000 x g for 1 minute. The column was then washed with 500 μL of buffer AW1 
followed by 500 μL of buffer AW2. DNA was eluted with 200 μL buffer AE (Qiagen 
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Inc., Valencia, CA). DNA concentration was measured using a NanoDrop ND1000 
Spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE, USA) and 
confirmed by gel electrophoresis on a 1% agarose gel. 
 
2.1.1.2 Extraction of plasmid DNA from A. tumefaciens 
Bacteria used for plasmid extraction were grown on fresh YEP plates containing 
approptiate antibiotics for two days at 28 °C. The antibiotic resistance of each strain can 
be found in Tables 8 and 9. Kanamycin was used at a concentration of 50 μg/mL, 
spectinomycin was used at a concentration of 100 μg/mL, and carbenicillin was used at 
concentration of 100 μg/mL. Bacterial colonies were selected and transferred to YEP 
liquid and grown overnight, for approximately 20 hours, with appropriate antibiotics, 
shaking at 28 °C at 250 rpm. Bacterial cultures were then centrifuged at 5000 x g for 10 
minutes at room temperature (25 °C) and plasmid DNA was extracted using the QIAprep 
Spin Miniprep Kit (Qiagen Inc., Valencia, CA) following the manufacturer’s instructions 
with a few minor alterations to increase yield of plasmid DNA. Twice the recommended 
amounts of buffers P1, P2 and N3 (Qiagen, Inc., Valencia CA) were used. Briefly, 
bacteria were resuspended in 500 μL of buffer P1, 500 μL of buffer P2 was then added 
and tubes were inverted six times. In the next step 600 μL of buffer N3 was added and 
tubes were mixed six times. Samples were then centrifuged at 13000 x g for 10 minutes 
at room temperature (25 °C) before transfer to a mini spin column. Because of the 
additional liquid caused by the increased volumes of buffers used, it was necessary to run 
the supernatant through the mini spin column in 2-3 aliquots. Spin columns were washed 
with 500 μL of buffer PB followed by 750 μL of buffer PE. A two-minute centrifuge step 
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was used to dry the spin column before elution with 50 μL of pure water. DNA 
concentration was measured using the NanoDrop ND1000 Spectrophotometer 
(NanoDrop Technologies, Inc., Wilmington, DE, USA) and confirmed by gel 
electrophoresis on a 1% agarose gel. 
 
2.1.1.3 Extraction of plasmid DNA from E. coli 
Plasmid DNA was extracted from E. coli using the QIAprep Spin Miniprep Kit 
(Qiagen Inc., Valencia, CA). Bacteria used for plasmid extraction were grown on fresh 
LB plates (25 g/L LB powder, 12g/L bacto agar, pH adjusted to 6.8 with NaOH) 
containing appropriate antibiotics for one night at 35 °C. Bacterial colonies were selected 
and transferred to LB liquid and grown with appropriate antibiotics overnight, for 
approximately 20 hours, shaking at 35 °C. Bacterial cultures centrifuged at 5000 x g for 
10 minutes at room temperature (25 °C) and plasmid DNA was extracted using standard 
protocols for QIAprep Spin Miniprep Kit similar to those described above 
 
2.1.2 Construction of A. tumefaciens mutants using homologous recombination 
All primers and plasmids, fragments, and bacterial strains used are listed in Tables 
6 through 9 in Appendix A. A. tumefaciens strain C58 was used as a wild-type strain to 
generate all mutant strains. In order to knockout or change desired regions of DNA, the 
method of homologous recombination was used. This method has been widely used and 
is a common way used to delete or alter bacterial gene sequences (Reid and Collmer, 
1987). A general overview of this process is illustrated in Figure 3. 
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2.1.2.1 Generation of knockout mutant strains ∆Pavc2, and ∆virC2 
Two different A. tumefaciens mutants (C58 ∆Pavc2 and C58 ∆virC2) were 
generated with genetic sequence deletions through homologous recombination. In order 
to knockout a gene using homologous recombination, up- and down-stream flanking 
sequences were selected that surround the region to be knocked out. These flanking 
sequences were then amplified from A. tumefaciens total DNA using PCR with primers 
that have included restriction sites, allowing for the fragment to be easily cloned into the 
sequencing vector pJET1.2 (ThermoFisher Scientific, USA). An initial sequencing step 
was used to check for mutations. Flanking sequences were then excised from of pJET1.2 
and cloned into the vector pTFsacB. By ligating the flanking sequences into pTFsacB, a 
sequence was generated that was identical to that in the A. tumefaciens genome but 
excluded the region to be knocked out. Using the natural process of homologous 
recombination, the chromosomal DNA was allowed to recombine with this sequence 
present on pTFsacB and the desired knockout mutants were generated. pTFsacB contains 
the nptII gene for kanamycin resistance along with the sacB gene, which prevents growth 
on media containing sucrose. In addition, there pTFsacB lacks an A. tumefaciens 
replication of origin in the plasmid so the plasmid could only persist if it was 
incorporated into the genome through an initial homologous recombination event, which 
was screened for using kanamycin resistance. A second recombination was detected by 
the ability of bacteria to grow on a medium containing sucrose. After two recombination 
events the native gene sequences were replaced with the gene sequences present on the 
pTFsacB vectors and knockout mutant will be generated. 
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The putative promoter region of anti-virC2 was identified using Softberry 
bacterial promoter prediction software (Solovyev and Salamov, 2011). A 42 bp region 
including the identified promoter sequence was targeted for deletion. Primers avcR1-UP-
F and avcR1-UP-R were designed to amplify the upstream flanking sequence (Appendix 
A, Table 6) while primers avcR1-DN-F and avcR1-DN-R were designed to amplify the 
downstream sequence. Restriction enzyme sites PstI, SalI and XbaI were built into the 
primers and used for all cloning steps. Total DNA from A. tumefaciens was used to 
amplify up and down stream flanking sequences. Fragments were then cloned into vector 
pJET1.2 and an initial sequencing step was used to check for possible mutations. A three-
piece ligation was then performed to ligate both up- and down-stream flanking sequences 
into the vector pTFsacB using the PstI/SalI/XbaI restriction sites. The resulting vector 
was named pAJ007. A detailed diagram of cloning used to generate pAJ007 can be found 
in Figure 4. 
The entire virC2 gene sequence was also knocked out using homologous 
recombination. Up-stream and down-stream sequences were identified and amplified 
using primers VC2KO-UP-F, VC2KO-UP-R, VC2KO-DN-F, and VC2KO-DN-R 
(Appendix A, Table 6). In addition, primers were designed to contain restriction sites 
PstI, KpnI and XbaI to be used for cloning steps. After an initial sequencing step to 
prevent any unwanted mutations using sequencing vector pJET1.2, these fragments could 
be ligated into the pTFsacB vector. The resulting vector, named pAJ021, was then used 
to generate the knockout mutant C58 ∆virC2. A detailed diagram of cloning used to 
generate pAJ021 can be found in Figure 5. 
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Each of the vectors used to generate knockout mutants was separately 
transformed into A. tumefaciens using electroporation. Bacteria were then screened for 
kanamycin resistance, indicating an initial recombination event and incorporation of the 
knockout vector. A second recombination event was detected by the ability of the 
bacteria to grow on sucrose. After the second recombination event bacterial colonies 
were screened for the ability to grow in the presence of sucrose indicating removal of the 
vector backbone. Presence of the knock-out region was then screened for using PCR 
primers vc2DR-F, vc2DR-R, VirC2F, and VirC2R (Appendix A, Table 6) and later 
confirmed by sequencing. 
 
2.1.2.2 Construction of FLAG-tagged A. tumefaciens mutants 
VirC2 protein was FLAG-tagged in several A. tumefaciens strains using 
homologous recombination. Design was carried out by Dr. Keunsub Lee while cloning 
steps listed in this section were carried out by Dr. Keunsub Lee with additional assistance 
as needed from myself. A gene fragment named 3xFLAG_virC2 (Appendix A, Table 7) 
was designed and cloned into vector pTFsacB for use in creating VirC2 FLAG-tagged 
mutant strains. A 1229 bp DNA fragment was designed to contain the virC2 coding 
sequence with an N-terminal 3xFLAG-tag inserted in frame directly after the start codon 
as well as an additional upstream flanking sequence. HindIII and BamHI restriction sites 
were also included to allow for cloning into vector pTFsacB. Fragments were ordered 
from Integrated DNA Technologies (IDT) and following digestion, were directly ligated 
into pTFsacB. The resulting vector was named pKL1007. A detailed diagram of cloning 
used to generate pKL1007 can be found in Figure 6. 
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pKL1007 was transformed into A. tumefaciens wild-type strain C58 where LB 
containing kanamycin was used to screen for an initial recombination event. A second 
recombination event was identified by screening for the ability of bacteria to grow on LB 
media containing sucrose. The presence of a FLAG-tag was further confirmed by PCR.  
 
2.2 Transcript Quantification 
 
2.2.1 Bacterial growth conditions 
For transcript analysis, bacteria were grown under induction conditions. Bacterial 
strains were stored in glycerol stock and streaked with a sterile inoculation loop on to 
fresh YEP plates with appropriate antibiotics and grown for three days at 28 °C. Colonies 
were selected and transferred to 5 mL YEP medium in a sterile 50 mL falcon tube along 
with appropriate antibiotics. Bacteria were grown overnight, for approximately 20 hours, 
in a 28 °C shaker at 250 rpm. 
Bacteria were transferred to 5 mL freshly made AB media (described below) from 
YEP cultures at a dilution of 1:100 and grown overnight, for approximately 20 hours, at 
28 °C shaking at 250 rpm. AB medium (one liter) was comprised of 50 mL 20x AB salts 
solution (20 g/L NH4Cl, 6 g/L MgSO4∙7H2O, 3 g/L KCl, 0.2 g/L CaCl2, 50 mg/L 
FeSO4∙7H2O, pH to 7 with KOH), 50 mL 20x AB buffer (60 g/L K2HPO4, 20 g/L 
NaH2PO4), and 900 mL sucrose water for a final sucrose concentration of 0.5%. Bacterial 
cultures were then centrifuged at 4000 x g for 10 minutes at room temperature (25 °C). 
The supernatant was discarded and bacteria were resuspended in two volumes of 
induction medium with 0.1mM of acetosyringone (AS) (Thermo Fisher Scientific, USA) 
Induction media (one liter) was comprised of 50 mL 20x AB salts solution as described 
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above, 2 mM NaPO4, 50 mM MES pH 5.6, and 0.5% glucose.  Identical cultures were 
grown without the addition of AS to serve as a non-induced comparison. Bacteria were 
then grown at 28 °C for 20 hours before isolation of RNA for transcript analysis. 
 
2.2.2 RNA isolation from A. tumefaciens 
RNeasy Protect Bacteria mini kit (Qiagen Inc., Valencia, CA) was used to isolate 
total RNA from A. tumefaciens cultures. This was carried out according to the 
manufacturer with minor alterations. All buffers and solutions were from the RNeasy 
Protect Bacteria mini kit (Qiagen Inc., Valencia CA), unless otherwise specified. In short, 
bacterial cultures grown with induction by AS were directly mixed with two volumes of 
RNAprotect bacteria reagent, vortexed, and incubated at room temperature (25 °C) for 
ten minutes. Cells were then centrifuged at 4000 x g for 10 min at room temperature (25 
°C).  
The pelleted cells were resuspended in 200 μL TE buffer, containing 1.5 mg 
lysozyme per mL and incubated at room temperature (25 °C) for 20 minutes with gentle 
vortexing every two minutes. Then 700 μL of buffer RLT was added and samples were 
mixed by vortexing. After mixing 500 μL of ethanol was added and samples were further 
mixed by pipetting. Samples were then centrifuged at 11,000 x g for 30 seconds at room 
temperature (25 °C) through the RNeasy mini spin column. An on-column DNase 
digestion was performed using DNase I (Invitrogen, USA) to eliminate DNA 
contamination followed by two washes with buffer RPE and elution with purified RNase 
free water. 
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Concentration of resultant RNA samples was measured using a NanoDrop 
ND1000 Spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE, USA). 
Samples were checked for residual DNA contamination and quality by gel 
electrophoresis. An additional step of DNase I treatment was then performed. The total 
RNA sample was incubated at 37 °C along with 2 μL of DNaseI (Invitrogen, USA), 1 μL 
of RNaseOUT RNase inhibitor (Invitrogen, USA), and 10 μL DNase I buffer for a total 
volume of 100 μL. After 30 minutes, an additional 2 μL of DNase I was added and 
samples were incubated for an additional 30 minutes. Following DNase treatment, 
samples were purified by phenol chloroform extraction and were then ready to use in 
downstream applications. 
 
2.2.3 cDNA preparation  
First, RNA was isolated as described above. Next, cDNA was synthesized from 
purified RNA using SuperScript III First-Strand Synthesis Kit (Invitrogen, USA). In 
short, primers were used to bind RNA transcripts and synthesize corresponding cDNA 
using PCR. Random hexamers were used to synthesize cDNA from total RNA transcripts 
while specific primers were used to synthesize specific cDNA transcripts. Typical 
reactions consisted of up to 6 μL RNA, 1 μL primer or random hexamer, 1 μL annealing 
buffer, and RNase free water up to a total volume of 8 μL. Reactions were incubated at 
65 °C for five minutes before the addition of 10 μL 2x First-Strand Synthesis Mix and 2 
μL SuperScript III Enzyme Mix. Reactions were then transferred to a thermocycler for 10 
minutes at 25 °C, followed by 50 minutes at 50 °C, and finally five minutes at 85 °C. 
cDNA volume was then adjusted to 200 μL and used for qRT-PCR  
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2.2.4 Quantification of transcripts using qRT-PCR 
qRT-PCR was used to quantify transcript expression levels. SYBR Green PCR 
Master Mix (applied Biosystems, USA) was used for qRT-PCR reactions. Primers were 
designed specifically for each amplified transcript and are listed in Appendix A Table 6. 
Housekeeping gene rpoD was used as an internal standard for comparison. qRT-PCR 
reactions consisted 5 μL cDNA, 12.5 μL SYBR Green PCR Master Mix, 2.5 μL primer, 
and 5 μL RNase free water. Reactions were carried out with the following profile: 15 
minutes at 95 °C, followed by 40 cycles of 15 seconds at 94 °C, 30 seconds at 55 °C, and 
30 seconds at 72 °C. This was followed by a data collection step at the end. Ct values 
were obtained and used to determine transcript levels relative to those of rpoD. 
 
2.3 Rapid Amplification of cDNA Ends 
3’ and 5’ RACE (Rapid amplification of cDNA ends) were both performed on the 
anti-virC2 transcript in order to determine transcription start and end sites. All RACE 
experiments were performed primarily by Dr. Keunsub Lee with assistance given by 
myself as needed.  
RNA samples isolated as described previously were used in both 5’ and 3’ RACE. 
5’ RACE began with a TAP (tobacco acid pyrophosphate, Epicentre USA) which was 
needed for ligation. Then, for both 3’ and 5’ RACE a specific adapter sequence was 
ligated to the end of the RNA sample (specific probes can be found in Appendix A, Table 
6) and PCR was used to synthesize first strand cDNA from the ligated RNA. For 5’ 
RACE, random hexamers were used and for of 3’ RACE, adapter specific primers were 
used. After first strand cDNA synthesis, transcripts of interest were amplified by PCR 
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with gene specific primers. Nested PCR was further used to ensure the correct target was 
amplified. PCR amplified fragments were then able to be cloned into sequencing vector 
pJET1.2 and sequenced.  
 
2.4 Western Blot Protocol 
 
2.4.1 Bacterial growth conditions and protein extraction 
A. tumefaciens strains were streaked from glycerol stocks onto fresh YEP plates 
and grown for two days at 28 °C before inoculation onto 5 mL of YEP liquid media. 
Liquid cultures were grown overnight, for approximately 20 hours, at 28 °C shaking at 
250 rpm, and pelleted by centrifugation for 10 minutes at 5000 x g at room temperature 
(25 °C). Pellets were then resuspended in 5 mL induction medium with a final OD600 of 
0.2 then grown overnight, for approximately 20 hours, at 28 °C shaking at 250 rpm, in 
the presence of 0.1 mM of AS.  
Protein was extracted by use of the freeze and thaw method. Bacterial cells were 
adjusted to an OD600 of 1.0 and equivalent volumes were centrifuged at 5000 x g for 10 
minutes at room temperature (25 °C). Pellets were then frozen for three minutes in liquid 
nitrogen and allowed to thaw on ice for 15 minutes. A phosphate buffered saline solution 
that was pH 7.2 (PBS) containing the protease inhibitor tablet SIGMAFast (Sigma 
Aldrich, USA) at pH 7.2 and 2 mg/mL Lysozyme was used to resuspend the bacterial 
cells. Samples were then allowed to sit on ice for at least 30 minutes. Samples were 
diluted at a 1:1 ratio with Laemmli sample buffer (BioRad, USA) containing β-
mercaptoethanol, boiled for five minutes in H2O and centrifuged at 10,000 x g for 30 
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minutes at 4 °C. The resulting supernatant contained the protein sample which was used 
to load into the gel. Total protein concentration was measured using a NanoDrop 
ND1000 Spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE, USA)  
 
2.4.2 Gel electrophoresis and Western blot 
Protein samples were run on a 1.5 mm 15% Acrylimide/Bis gel at 200 volts until 
loading dye from the samples reached the bottom of the gel. Along with samples, 
Precision Plus Protein Standards (BioRad, USA) were also included. Proteins were then 
transferred to a 0.2 μm nitrocellulose membrane (BioRad, USA) for further probing. 
Semi-dry transfer was performed at 25 volts for 30 minutes.  
Membrane with transferred protein was blocked overnight, for 16 hours, at 4 °C 
in 5% non-fat milk in PBS. The membrane was rinsed once with 1x PBS for five minutes 
followed by incubation with primary antibody for two hours shaking at room temperature 
(25 °C). The primary antibody was diluted in a solution of 1% non-fat milk in PBS to a 
concentration of ~0.33 μg/mL. In order to detect the FLAG signal rabbit-antiFLAG 
antibodies (Sigma Aldrich, USA) were used as the primary antibody.  
Following incubation with primary antibody, the membrane was washed three 
times for five minutes each time with PBS with 0.1% Tween 20 (PBST). The membrane 
was then incubated with a 1% dry milk in PBS solution containing ~ 0.13ug/mL of 
secondary antibody shaking at room temperature (25 °C) for one hour. A goat-anti rabbit 
antibody conjugated with horseradish peroxidase (Thermo Fisher Scientific, USA) was 
used as the secondary antibody. After this incubation, the membrane was washed three 
times for five minutes each time in 1x PBST.  
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SuperSignal West Pico Chemiluminescent Substrate (ThermoFisher Scientific, 
USA) was then used to detect signal from secondary antibodies. Membranes were 
incubated with chemiluminescent substrate for one minute then moved into the dark room 
for development with X-ray film. 
 
2.4.3 Protein quantification with ImageJ software 
The free downloadable software ImageJ was used to quantify band intensity in 
Western Blot experiments (Schneider et al., 2012). X-Ray films were scanned and 
uploaded before being opened in ImageJ. The software was then used to calculate the 
area of each band. Using total protein values in each sample, band area over total protein 
was able to be quantified. Total protein measurements were obtained using the NanoDrop 
ND1000 Spectrophotometer. These numbers were then used to compare amounts of 
FLAG-tagged protein between strains of A. tumefaciens. 
 
2.5 AGROBEST Experiments 
AGROBEST experiments have been previously described by Wu et al. (2014). 
The group used GUS (β-glucuronidase) gene expression to compare rates of infection by 
A. tumefaciens in Arabidopsis thaliana. Graciously, the group assisted by sharing their 
methods for these experiments. The following methods are heavily credited to Dr. Erh-
Min Lai’s Laboratory at the Institute of Plant and Microbial Biology in Taiwan. 
 
58 
 
2.5.1 Plant material 
Arabidopsis thaliana seedlings were used in AGROBEST experiments. Wild-type 
Col-0 seeds were donated from Dr. Yanhai Yin’s lab at Iowa State University. Only Col-
0 plants were used for the AGROBEST assays described here.  
 
2.5.2 Plant growth conditions 
To grow plants for AGROBEST experiments, seeds were first sterilized for 10 
minutes in a 50% bleach, and 0.05% Tween-20 solution by inverting in a 1.5 mL 
microcentrifuge tube. Seeds were then rinsed five times with sterile water and transferred 
to 1 mL of ½ MS media (2.17 g/L Murashige and Skoog basal medium pH adjusted to 
5.7 with KOH) with 0.5% sucrose in a 6 mm petri dish sealed with parafilm and 
incubated at 4 °C for two days before they were transferred to the growth chamber. Plants 
were grown at 24 °C with a 16-hour day length. After four days of growth, seedlings 
were infected with the desired A. tumefaciens strains. 
For infection, a sterile inoculation loop was used to transfer seedlings to a new 6 
mm petri dish with approximately 20 seedlings per dish. Then 1 mL of bacterial culture 
with an OD600 of 0.02 in ½ induction, ¼ MS media was added. Acetosyringone (AS) was 
also added to a final concentration of 0.01mM to induce bacterial virulence. Finally, 
dishes were sealed with parafilm. 
After infection, seedlings continued to grow under the conditions described above 
for two additional days. On the third day medium was removed from seedling dishes and 
replaced with 1 mL of new ½ MS media containing 0.5% sucrose and timentin to a final 
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concentration of 1 mM. Seedlings were then allowed to grow for one additional day 
before analysis. Methods for plant growth were adapted from Wu et al. (2014).  
 
2.5.3 Bacterial growth conditions 
AGROBEST experiments were used to examine virulence of the following 
bacterial strains C58(pB35S GUS), C58 ∆Pavc2R1(pB35S GUS), C58∆virC2(pB35S 
GUS), C58∆virG(pB35SGUS) and C58. Each bacterial strain was transformed with the 
plasmid pB35S-GUS, which expresses the GUS gene driven by the cauliflower mosaic 
virus 35S (35S) promoter. Because the plasmid also contained right and left border 
sequences flanking the GUS gene, this fragment of DNA was transferred in a transient 
fashion to the plant where GUS expression could then be measured.  
Bacteria were stored in glycerol stocks at -80 °C and streaked with a sterile 
inoculation loop on fresh YEP plates containing appropriate antibiotics, which were then 
sealed with parafilm. Bacteria were grown on plates for three days at 28 °C. Cells from a 
fresh plate were transferred with a sterile inoculation loop to 5 mL of 523 liquid medium 
(8 g/L Casein Hydrolysate, 0.0358 g/L MgSO4∙7H2O, 2 g/L K2HPO4, 10 g/L sucrose, and 
4 g/L Yeast Extract, pH adjusted to 7.0 with KOH) in a sterile 50 mL falcon tube with 
appropriate antibiotics. Bacteria were then grown in a 28 °C shaker at 250 rpm overnight, 
for approximately 20 hours. Next, bacterial cultures were centrifuged at 4000 x g for 10 
minutes at room temperature (25 °C). The Supernatant was removed and the bacteria 
were resuspended in induction medium, and 5 mL of this induction culture was 
transferred to a new 50 mL falcon tube along with 0.1 mM AS to an OD600 of 0.2 This 
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culture was then grown for 16-20 hours shaking at 28 °C at 250 rpm after which time it 
could be used for infection. 
Directly before the infection process bacteria were again centrifuged as described 
above. The supernatant was removed and bacteria were then diluted in fresh ½ induction, 
¼ MS media to an OD600 of 0.02 at which stage they could be added to Arabidopsis 
thaliana seedlings. The details of this protocol were adapted from Wu et al. (2014). In 
this study, AGROBEST was used to examine the expression of GUS, as well as other 
genes in A. thaliana seedlings. 
 
2.5.4 GUS quantification protocol 
The GUS substrate 4-methylumbelliferyl β-D-glucuronide (MUG) was used to 
quantify the amount of GUS expressed in Arabidopsis thaliana seedlings. When GUS 
acts as an enzyme on the MUG substrate, MUG is broken into two separate molecules. 
One of these molecules, 4-methylumbelliferone (4MU) is fluorescent. The level at which 
fluorescence from 4-MU increases over time corresponds to the level of GUS in the 
sample. 
Ten seedlings were chosen at random from one petri dish to be used as a sample 
in order to obtain a sample representative of all the plants in the dish. Plants were 
removed with a sterile inoculation loop and blotted dry on sterile paper towel before 
being placed in a 1.5 mL microcentrifuge tube and immediately frozen in liquid nitrogen. 
Once all samples had been collected, frozen plant material was ground into powder with 
a sterile plastic drill bit followed by the immediate addition of 400 μL extraction buffer 
(50 mM phosphate buffer pH 7.0, 10 mM EDTA, 0.1% SDS, 0.1% Triton X-100, 10 mM 
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β-mercaptoethanol, and protease inhibitor tablet SIGMAFast (Sigma Aldrich, USA)). 
Samples continued to be ground for one to two minutes in extraction buffer and placed on 
ice till all samples were processed. Samples were then centrifuged at 13000 x rpm for 15 
minutes at 4 °C. The resulting supernatant was then transferred to a new 1.5 mL 
microcentrifuge tube, placed on ice and was analyzed for GUS activity using the MUG 
substrate. 
To analyze for GUS using MUG, 20 μL of sample and 180 μL of 10 mM MUG in 
extraction buffer were combined in each well of a black 96 well plate with a clear 
bottom. Three technical replicates were performed per sample. Fluorescent activity was 
then measured for one hour using a plate reader. A 356 nm excitation and 455 nm 
emission filter was used with a sensitivity setting of 75. The slope of increasing 
fluorescence could then be calculated and compared between samples.  
In order to standardize experiments, a standard curve was developed using 
concentrations of 4-MU at 5 mM, 2.5 mM, 1.25 mM, and 0.625 mM of 4-MU. This 
allowed the GUS activity to be related from one experiment to the next. The slope of 
each sample could then be reported in terms of pMol 4-MU per minute. 
Total protein present in a sample was calculated using Bradford analysis with 50 
μL of each sample added to 950 μL of Bradford solution in a 2 mL cuvette. The OD of 
samples was measured with a spectrophotometer set at 595 nm using plain Bradford 
solution as a blank. A standard curve was constructed using ten concentrations of bovine 
serum albumin (BSA) ranging from 0.01 to 1 mg/mL. GUS activity could then to be 
reported as pMol 4-MU/minute/mg protein.  
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2.5.5 GUS staining protocol 
In order to visualize GUS expression within Arabidopsis thaliana tissues, 5-
bromo-4-chlorohexyl-ammonium salt (X-Gluc) was used as a substrate to stain 
Arabidopsis thaliana seedlings. At three days post infection, seedlings not needed for 
GUS quantification with MUG were incubated in X-Gluc solution (50 mM NaHPO4 pH 
= 7, 5 mM KFerricyanide, 5 mM KFerrocyanide, 0.1% Triton X100, 1% DMSO, 1.5 mM 
X-Gluc). Seedlings to be analyzed for GUS expression were placed in 1.5 mL 
microcentrifuge tubes with a sterile inoculation loop and kept on ice until all samples 
were collected. After collection, samples were taken off ice and a 90% acetone, 10% 
water solution was added. The tubes were incubated at room temperature (25 °C) for 20 
min in order to fix the tissues. Acetone solution was then removed using a pipet and 
samples were rinsed once with sterile water. Next, X-Gluc solution was added until all 
tissues were covered (approximately 750 μL per sample). Tubes were then incubated at 
37 °C for four hours in the dark.  
After the incubation period the X-Gluc solution was removed and replaced with a 
70% ethanol, 30% H2O solution to remove chlorophyll from the tissues. The following 
day, samples were photographed. Samples were stored for future reference. 
 
2.6 Tumorigenesis Assays using Kalanchoe daigremontiana 
 
2.6.1 Plant material 
Kalanchoe daigremontiana were used for tumor inoculation. Plants were either 
purchased from an online vendor or were donated from Dr. Stan Gelvin’s group at 
Purdue University. Plants were grown at room temperature (25 °C) with light for either 
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16 or 12 hours a day. Plants were watered roughly once a week and were checked 
frequently for dryness. In order to propagate new plants, small plantlets were taken from 
older plants that had never been inoculated and were germinated in soil in the same 
growth chamber.  
 
2.6.2 Bacterial growth conditions 
Bacterial strains were stored in glycerol stock and streaked with a sterile 
inoculation loop on to fresh YEP plates with appropriate antibiotics and grown for two 
days at 28 °C. In order to grow bacteria in liquid culture, cells were taken from a fresh 
plate with a sterile inoculation loop and added to 5 mL YEP media in a sterile 50 mL 
falcon tube along with appropriate antibiotics. Bacteria were then grown overnight, for 
approximately 20 hours, in a 28 °C shaker at 250 rpm.  
For induction, bacteria were transferred to 5 mL fresh AB media from YEP 
cultures at a dilution of 1:100 and grown overnight, for approximately 20 hours, at 28°C 
shaking at 250 rpm. Bacterial cultures were then centrifuged at 4000 x g for 10 minutes at 
room temperature (25 °C). The supernatant was removed and bacteria were resuspended 
in two volumes of induction media with 0.1mM of AS. Bacteria were then grown at 28 
°C for 20 hours before use for plant inoculations.  
Regardless of the growth conditions, directly before inoculation, bacteria were 
centrifuged at 4000 x g for 10 minutes at room temperature (25 °C). The supernatant was 
removed and the pellet resuspended in 0.9% NaCl solution. Bacteria were centrifuged a 
second time as described above. The supernatant was discarded and the pellet was 
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resuspended in 0.9% NaCl solution to an OD600 of 1.0. This solution was then used for 
inoculation of K. daigremontiana. 
 
2.6.3 Kalanchoe daigremontiana inoculation procedures 
For inoculation, Kalanchoe daigremontiana plants were selected that were 
approximately six weeks of age. By inoculating plants of various ages, we observed that 
younger plants consistently had a higher response to inoculation by A. tumefaciens while 
older leaves consistently showed no tumors post inoculation. 
At the time of inoculation, a sterile needle was used to create four linear wounds 
on each side of the leaf’s midrib for a total of eight wounds per leaf. After wounding 5 μL 
of bacterial solution prepared in 0.9% NaCl solution (as described above) was then 
applied to each wound site with a sterile pipet tip. In all experiments wild type was 
inoculated on one side of the midrib while a mutant strain was inoculated on the opposite 
side in order to generate a direct comparison 
After inoculation, plantes were placed back into the growth chamber and 
continued to grow under normal conditions until tumors were formed (~3 weeks). After 
the formation of tumors, leaves were photographed and tumors were scored from 0-3 
with 0 being no tumor and 3 being a very large tumor. 
 
2.7 Statistical Analysis 
In order to determine the significance of experimental results, a variety of 
statistical tests were used. Due to the complicated nature of some sets of data, additional 
statistical assistance was received from Yinan Fang from the Statistics Department at 
Iowa State University. Specifically, data from AGROBEST experiments and K. 
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daigremontiana tumorgenicity assays were analyzed by Yinan Fang. Data from qRT-
PCR experiments and Western blot experiments were analyzed by myself with additional 
assistance from Dr. Keunsub Lee as needed.  
 
2.7.1 Statistical analysis of qRT-PCR data 
qRT-PCR data were collected and used to measure transcript levels which were 
then able to be compared between different strains of A. tumefaciens. Values for each 
transcript were first reported in Ct (cycle threshold) then changed to relative abundance 
when normalized to housekeeping gene rpoD. These values were also able to be 
normalized to C58 wild-type values. Experiments were performed with biological 
replicates which were then compared using a two-tailed Student’s paired-sample t-test. In 
this model the dependent variable (transcript level) is compared between the two bacterial 
strains. Significance was declared at P < 0.05. 
 
2.7.2 Statistical analysis of Western blot images 
In order to detect changes in amounts of FLAG-tagged VirC2 protein between the 
two A. tumefaciens strains, C58::VirC2FLAG and C58 ∆Pavc2::VirC2FLAG, equal 
volumes of protein samples from each strain were run side-by-side in Western blot. 
ImageJ (Schneider et al., 2012) was then used to quantify the band area. The amount of 
total protein in each sample was used to standardize each sample. Final values reported in 
band size over mg/mL total protein were compared. Three separate paired biological 
replicates were performed for each strain and compared using a paired-sample two-tailed 
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Student’s t-test. In this model the dependent variable (protein) was compared between the 
two bacterial strains. Significance was declared at P < 0.05. 
 
2.7.3 Statistical analysis of Kalanchoe daigremontiana tumorigenesis assays 
Statistical analysis was performed on results from K. daigremontiana 
tumorigenesis experiments using a generalized linear mixed model for ordinal variables 
(GLIMMIX). This model is appropriate when working with a multinomial distribution, in 
this case, we are working with the tumor score from 0 to 3. Using this model, an F-test 
was used to test the fixed effects. In this case, fixed effects were the particular bacterial 
strain used. A significant result meant the bacterial strain used caused a difference in 
tumor result. A value of less than 0.05 was considered significant. It is important to note 
that for the data set comparing tumors produced from C58 and C58 ∆virC2 under nutrient 
rich conditions, the model used did not fit the data no tumors at all were produced by C58 
∆virC2 (the data did not converge). However, results were still considered to be 
statistically significant since the difference could be clearly seen and was greater than 
other samples found to be statistically significant. In addition, a significant likelihood 
ratio test was used to compare the distributions with and without factoring in bacterial 
effect. Because this test was significant (P < 0.001) it can be said that the effect of the 
bacterial strains were indeed significant. 
 
2.7.4 Statistical Analysis of AGROBEST experiments 
Results from AGROBEST experiments were analyzed using a linear mixed 
model. In this case, the response variable was the GUS expression while the specific 
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bacterial strain used was the fixed effect. The difference of least squares mean was then 
compared between treatments. This is a common way to examine the difference in means 
between several groups. A Bonferroni adjustment was also used in order to control for 
possible type I error (less chance of a false positive) and significance was declared at P < 
0.05. 
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Figure 3. General strategy for homologous recombination used to alter genomic 
sequences of A. tumefaciens. Homologous recombination was used to generate knockout 
mutant strains C58 ∆Pavc2 and C58 ∆virC2. A homologous recombination strategy was 
also used to generate FLAG-tagged strains including C58::VirC2-FLAG (based on Reid 
& Collmer, 1987). 
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Figure 4. Cloning strategy used to generate pAJ007. Vector pAJ007 was generated for 
the purpose of deleting the promoter region of anti-virC2. Upstream and downstream 
sequences flanking the region to be deleted were cloned into vector pTFsacB to generate 
pAJ007. 
71 
 
 
Figure 5. Cloning strategy used to generate pAJ021. Vector pAJ021 was generated for 
the purpose of deleting the entire virC2 gene. Upstream and downstream stream 
sequences flanking the region to be deleted were cloned into vector pTFsacB to generate 
pAJ021. 
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Figure 6. Cloning strategy used to generate pKL1007. 3xFLAG_virC2, a 1229 bp 
fragment designed to generate A. tumefaciens strains with N-terminally tagged VirC2 
protein was ordered from IDT.  
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CHAPTER III 
RESULTS 
 
3.1 Selection of a Regulatory RNA in A. tumefaciens for Further Investigation 
 
3.1.1 Many non-coding RNA’s are present in the A. tumefaciens genome 
In order to identify regulatory RNAs present in A. tumefaciens, an assistant 
research scientist in the lab, Dr. Keunsub Lee, performed large-scale RNA sequencing 
experiments previously described (Lee et al., 2013). By sequencing RNA samples from 
A. tumefaciens grown under a variety of conditions, Lee et al. (2013) was able identify 
385 “novel non-coding RNA’s”. A similar study was performed by Wilms et al. (2012), 
identifying over 200 potential regulatory RNA transcripts in A. tumefaciens. While it is 
not certain which of these identified transcripts act to regulate expression of other genes, 
these transcripts form a pool of RNA transcripts worth further investigation. Post-
identification, individual non-coding RNAs were then able to be selected and further 
explored for their specific roles and functionality. 
 
3.1.2 Selection of anti-virC2 transcript for further study 
The abundance of candidate regulatory RNAs expressed in A. tumefaciens 
resulted in difficulty when attempting to select a RNA to investigate further. In order to 
narrow the field, only regulatory RNA’s located in the vir gene region of the Ti plasmid 
were examined and further explored. It was decided to focus on the vir region because of 
the vir genes’ essential role in plant transformation. We selected a candidate regulatory 
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RNA encoded in this region, to increase the probability that the candidate RNA transcript 
would play a role in pathogenic virulence and plant transformation. 
By examining RNA sequencing data previously generated by Lee et al. (2013), a 
large difference between virC1 and virC2 gene expression was observed (Figure 7). As 
shown by these sequencing data, when bacteria were grown under AS inducion 
conditions, virC1 had much higher transcript expression levels than virC2. This 
observation was also reported by Wilms et al. (2012), observing virC1’s greater increase 
in upregulation than that of virC2 under induction conditions.  
Because virC1 and virC2 are part of the same operon, it makes sense that 
transcription would produce a polycistronic mRNA with similar transcript abundances for 
both virC1 and virC2. Why then, is there a large difference in expression between the two 
genes which make up the virC operon? One possible explanation for the lower level of 
virC2 transcript compared to those of virC1 could be the common phenomenon observed 
through gene strand-specific tiling arrays and transcriptome sequencing in bacterial 
operons in which each subsequent gene in the operon is transcribed at a slightly lower 
rate than the preceding gene (Güell et al., 2009). Or perhaps the two transcripts have 
differing rates of stability with virC2 quickly degrading. Another possible explanation 
could involve regulation by regulatory RNA. Perhaps anti-virC2 is acting to negatively 
regulate the virC2 transcript.  
Upon examination of previously identified non-coding RNA candidates, an RNA 
transcript was observed to be expressed from the antisense strand of the virC2 gene (Lee 
et al., 2013). Due to this arrangement, the anti-virC2 transcript would have perfect 
complementarity with the virC2 mRNA. Therefore, we hypothesized that the anti-virC2 
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transcript acts in cis to downregulate its potential target, virC2. If this hypothesis is 
correct, it would explain the lower virC2 expression observed when compared to that of 
virC1. With this hypothesis in mind, we decided to further investigate the anti-virC2 
transcript and its potential role in regulation of virC2 as well as other possible roles in 
pathogenic virulence. 
This candidate regulatory RNA was also identified by Wilms et al. (2012) and 
named Ti4 though its function was not further explored. For this work this RNA 
transcript was called anti-virC2 or avc2 for short. 
 
3.1.3 Expression of the anti-virC2 transcript 
From the RNA sequencing data obtained by Lee et al. (2013), the expression 
pattern of avc2 had already been determined (Figure 7). We observed that avc2 was 
expressed in A. tumefaciens under all conditions, although expression was slightly higher 
under conditions in which bacteria were induced with AS. An expression pattern 
consisting of three (possibly four) regions of high expression, separated by valleys of low 
expression, were also notable and can be observed in Figure 7.  
 
3.2 Examination of anti-virC2 Transcription Start and Stop Sites 
The exact 5’ and 3’ sites of avc2 were not clear. As seen in the transcript profile, 
three, possibly four, different, regions of high sequence reads were present on the anti- 
virC2 gene (Figure. 7). In order to identify the 5’ and 3’ ends of the avc2 transcript, as 
well as to determine whether the transcript was expressed as three separate RNAs or a 
single RNA, both 3’ and 5’ RACE (Rapid Amplification of cDNA ends) were carried out.  
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RACE reactions were primarily performed by Dr. Keunsub Lee with additional 
assistance as needed from myself. Sequencing results from these RACE experiments 
revealed the 3’ and 5’ sites for each of the three regions of the avc2 transcript (Figure 8). 
From examining the resulting sequencing data, it appears that there is a clear 5’ end at 
nucleotide position 194400 for anti-virC2 region 1. However multiple 5’ ends were found 
for regions 2 and 3. Multiple 3’ ends were also observed for each of the three regions 
(Figure 8). 
There are several things that may be indicated by these RACE findings. First, and 
most importantly, the definite transcription 5’ end of avc2 region 1 at nucleotide position 
194400 indicates the beginning of the anti-virC2 transcript. Data from these RACE 
experiments also confirm that anti-virC2 transcript is indeed expressed.  
 Second, because 5’ ends for region 2 and 3, and 3’ ends for all three regions were 
unclear this indicates there may be multiple versions of the avc2 transcript which are 
expressed. It is also possible that the avc2 transcript may be expressed in three separate 
transcripts or one single transcript depending on environmental conditions. Differential 
expression of RNA transcripts has been previously observed depending on environmental 
conditions (Waters and Storz, 2009). Perhaps the different transcript lengths act to 
regulate biological processes within the cell depending on environmental conditions.   
However, one thing is certain, there is gene expression coming from this region 
opposite virC2 with one clear start site at nucleotide position 194400 on the Ti plasmid. 
Because the exact expression of the avc2 transcript remains unclear, the entire region 
opposite virC2 was examined together.  
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3.3 Generation of Deletion Mutants C58 ∆Pavc2 and C58 ∆virC2 
Once it became clear that the avc2 transcript was expressed opposite the virC2 
sequence through RACE experiments and sequencing data, the next logical step in 
elucidating avc2’s function was to alter its expression. Once levels of avc2 were changed, 
other transcripts could be analyzed for resultant changes in expression.  
Because the avc2 transcript is expressed directly opposite the virC2 coding gene, 
a total knockout mutant was impossible to generate without also removing the virC2 
gene. To overcome this obstacle, the promoter region of avc2 was identified and deleted.  
 
3.3.1 Generation of anti-virC2 promoter deletion mutant ∆Pavc2 
The promoter region of avc2 was identified using Softberry BPROM; Bacterial 
promoter prediction software (Solovyev and Salamov, 2011). After input of the avc2 
region sequence both a -35 box and -10 box region were identified (Figure 9). A 46 base 
pair region of the A. tumefaciens genome was then selected for deletion. The region 
included the identified avc2 promoter without including any of the virC2 coding 
sequence, or any other virulence gene coding sequence (Figure 9).  
In order to delete the avc2 promoter region a strategy of homologous 
recombination was implemented using vector pTFsacB (Figure 3). The resulting avc2 
promoter deletion mutant was named C58 ∆Pavc2. Additional details concerning the 
construction of C58 ∆Pavc2 can be found in Chapter II Materials and Methods. 
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3.3.2 Generation of virC2 deletion mutant ∆virC2 
In addition to the avc2 promoter deletion mutant C58 ∆Pavc2, a mutant strain of 
A. tumefaciens was generated in which the entire coding region of the virC2 gene was 
removed along with the promoter region of anti-virC2. This was accomplished using 
homologous recombination to delete a 679 bp region of the A. tumefaciens genome. The 
resulting bacterial strain was names C58 ∆virC2. Additional details concerning the 
construction of C58 ∆virC2 can be found in Chapter II Materials and Methods. 
 
3.4 Analysis of Transcript Expression Level Changes in anti-virC2 Promoter Deletion 
Mutant C58 ∆Pavc2 
Upon deletion of the anti-virC2 promoter region, it was necessary to perform 
qRT-PCR in order to measure changes in the transcript expression levels of anti-virC2 as 
well as other virulence genes of interest. QRT-PCR experiments described here were 
performed primarily by Dr. Keunsub Lee with assistance as needed from myself.  
 
3.4.1 Deletion of predicted anti-virC2 promoter leads to reduction of anti-virC2 
transcript  
Initial qRT-PCR experiments were performed in order to examine transcript 
expression level in the newly generated mutant C58 ∆Pavc2. Both C58 wild type and 
C58 ∆Pavc2 were grown up under induction conditions as described in Materials and 
Methods Chapter II. RNA was then extracted and cDNA synthesized using strand-
specific primers for anti-virC2, virC2 and virC1 transcripts. cDNA for housekeeping 
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gene rpoD was also synthesized with gene specific primers and used as an internal 
standard in order to compare levels of transcript between bacterial strains. 
Three experiments with a total of eight biological replicates of strand-specific 
qRT-PCR were performed to measure transcript expression level. Based on the results 
from these experiments, it was observed that deletion of the avc2 promoter region in 
mutant C58 ∆Pavc2 did indeed cause a reduction in of avc2 transcript expression level 
(Figure 10, Table 2). When compared to wild type, expression levels of avc2 transcript 
were reduced by 39%  ± 6.5% in C58 ∆Pavc2 (P < 0.001).  
This reduction of anti-virC2 transcript was also confirmed through regular, non-
strand specific qRT-PCR (Figure 11, Table 3). One experiment with three biological 
replicates was performed to amplify transcripts from virC2/anti-virC2, virG, and rpoD 
regions in both C58 wild type and C58 ∆Pavc2 which had been grown under induction 
conditions as described in Chapter II Materials and Methods. In contrast to strand-
specific qRT-PCR experiments, cDNA for these regular qRT-PCR was synthesized with 
random hexamers instead of gene specific primers. Because of this, transcripts located 
opposite each other at the same location in the genome were not able to be differentiated. 
Most importantly, expression of anti-virC2 would be impossible to differentiate from that 
of virC2 since the two genes share the same location.  
In order to examine expression levels of only anti-virC2 transcript, bacterial 
samples which had been grown without induction by AS were examined. As observed in 
previous sequencing data obtained by Lee et al. (2013), without induction the virC2 
mRNA is barely expressed (Figure 7). By examining transcript expression levels from the 
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anti-virC2/virC2 region under no induction conditions we are able to assume the vast 
majority of transcript is from anti-virC2.  
When comparing relative expression of anti-virC2 transcript in C58 wild type 
versus C58 ∆Pavc2, an average reduction of 49% ±10.0% was observed (P = 0.037) 
(Figure 11). 
Together, both strand-specific and regular qRT-PCR confirm that knockout of the 
anti-virC2 promoter region did indeed lead to a decrease in the expression level of anti-
virC2 transcript present in C58 ∆Pavc2. Once this reduction had been confirmed, the 
effect of lower anti-virC2 abundance was able to be further examined in C58 ∆Pavc2 and 
compared with C58 wild-type. 
 
3.4.2 Reduction of anti-virC2 transcript in C58 ∆Pavc2 does not alter virC2 or 
virC1 mRNA transcripts 
We had hypothesized that the anti-virC2 transcript acts to down regulate the 
mRNA transcript of virC2, if true, it would be expected that expression of the virC2 
transcript would be higher in the C58 ∆Pavc2 mutant, due to the reduction in avc2 
transcript. From the previously mentioned strand-specific qRT-PCR experiments, 
expression levels of the virC2 transcript were examined and compared between the two 
strains. Instead of observing a reduction in virC2 transcript expression level, there 
appeared to be no significant difference between virC2 transcript in C58 and C58 ∆Pavc2 
(Figure 10, Table 2).  
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During strand-specific qRT-PCR experiments, abundance of virC1 mRNA was 
also examined. When comparing abundance of virC1 transcript between C58 and C58 
∆Pavc2 there appears to be no significant change between the two strains.  
Based on strand-specific qRT-PCR experiments, there does not seem to be any 
change in the expression level of virC2 or virC1 transcript expression level when there is 
a reduction in avc2. Together, these findings suggest the avc2 transcript does not act in 
cis to regulate the virC2 transcript encoded on the opposite strand. Nor does avc2 act to 
regulate the other gene on the virC operon, virC1  
 
3.4.3 Additional transcript changes are observed in C58 ∆Pavc2 when compared to 
C58 wild type 
While performing regular qRT-PCR to compare virC2/anti-virC2 transcript 
expression level in C58 and C58 ∆Pavc2, virG and virB1 transcript expression levels 
were also examined (Table 3). Because there was no alteration in virG coding sequence 
in A. tumefaciens mutant C58 ∆Pavc2, there was not expected to be any change in virG or 
virB1 transcript expression level. However, an increase in expression level of both virG 
and virB1 transcripts were observed in C58 ∆Pavc2. Abundance of virG transcript nearly 
doubled (P = 0.0386) while virB1 transcript levels were elevated by ~25% in C58 
∆Pavc2 when compared to wild type but not enough to be statistically significant.  
There may be several reasons for this higher expression of virG. First the deletion 
of the avc2 promoter region may have caused a change in the expression of the virG 
transcript. While the virG coding sequence is not directly affected, the deletion of a 
directly downstream region may have caused a change in virG transcript expression. It 
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may also be possible that the avc2 transcript regulates the virG transcript either directly 
or indirectly. While the reason for the elevated level of virG transcript is unknown, it is 
important to note, and may be the subject of future investigation.  
 
3.5 Analysis of VirC2 Protein Expression in anti-virC2 Promoter Deletion Mutant 
∆Pavc2 
Changes in transcript expression level are important. However, it is necessary to 
check for changes in corresponding protein concentration as well. An observed change in 
mRNA expression level does not necessarily correspond to a change in the amount of 
protein. Examining protein concentration in the anti-virC2 promoter deletion mutant was 
especially important to confirm data from qRT-PCR experiments. Here, expression levels 
of VirC2 protein are measured and compared between A. tumefaciens strains C58 and 
C58 ∆Pavc2.  
 
3.5.1 Generation of FLAG-tagged VirC2 protein in C58 and C58 ∆Pavc2 
In order to measure concentrations of the VirC2 protein, an A. tumefaciens strain 
was generated containing an N-terminal 3x FLAG-tag on the native VirC2 protein. 
Additional mutant strains were generated which contained an N-terminal 3x FLAG-tag 
on the native VirC1 and VirG proteins respectively. However, VirC1 and VirG proteins 
failed to visualize during Western blot after numerous methods were used to extract 
protein. For the scope of the main thesis, only VirC2 FLAG-tagged protein 
concentrations will be examined. Additional information regarding A. tumefaciens strains 
containing VirG and VirC1 FLAG-tagged proteins can be found in Appendix B. Design 
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of VirC1 and VirC2 FLAG-tag mutants was carried out by Dr. Keunsub Lee, while 
design of VirG FLAG-tagged mutant was by myself. All cloning steps were performed 
by Dr. Keunsub Lee or myself. 
These bacterial strains containing an N-terminal FLAG tag were named C58 
∆Pavc2::VirC2-FLAG and C58::VirC2-FLAG and were used for comparison of VirC2 
protein concentrations. Reassuringly a similar N-terminally FLAG-tagged VirC2 protein 
was used with success by another group (Atmakuri et al., 2007). 
 
3.5.2 VirC2 protein levels are unchanged in C58 ∆Pavc2 when compared to wild 
type 
Western blot was performed to compare concentrations of VirC2 protein. After 
bands of VirC2-FLAG were developed on film, ImageJ (Rasband, 2012) was used to 
compare size of the bands. These results could then be standardized to the total amount of 
protein present in each sample using measurements taken with the NanoDrop ND1000 
Spectrophotometer. Taking results from each of three experimental replicates, there does 
not appear to be a difference in VirC2-FLAG protein expressed in when comparing C58 
and C58 ∆Pavc2 (Figure 12C). From these results it can be concluded that deletion of the 
avc2 promoter region, in C58 ∆Pavc2 does not lead to a decrease in concentration of 
VirC2 protein when compared to wild type.  
This observation confirms the findings of qRT-PCR experiments showing no 
change in virC2 transcript expression levels between C58 and C58 ∆Pavc2. Because 
amounts of both VirC2 protein and transcript were observed to remain unchanged in C58 
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∆Pavc2, it is likely that the avc2 transcript plays no role in regulation of the virC2 
transcript as previously hypothesized.  
 
3.6 Examination of Virulence in A. tumefaciens Mutant Strains C58 ∆Pavc2 and C58 
∆virC2 
Two different methods were used to screen for changes in virulence within the 
knockout mutant strains C58 ∆Pavc2 and C58 ∆virC2 compared to wild type strain C58. 
First, the plant species Kalanchoe daigremontiana was used for inoculation experiments 
in which resultant tumors were then compared. K. daigremontiana inoculations have 
been commonly used as a way to compare bacterial virulence between strains of A. 
tumefaciens (Garfinkel and Nester, 1990). Second, AGROBEST experiments were used 
to quantitatively measure the ability of bacteria to infect and transiently express 
transferred DNA in Arabidopsis thaliana. AGROBEST experiments are not unique to 
this thesis and were previously used to transiently express various genes in A. thaliana 
(Wu et al., 2014). 
 
3.6.1 Measurement of virulence in knockout mutants C58 ∆Pavc2 and C58 ∆virC2 
by Kalanchoe daigremontiana tumorigenesis Assays.  
As described previously in Chapter I, Introduction and Literature Review, 
Kalanchoe daigremontiana inoculations are a commonly used method to detect changes 
in virulence (Garfinkel and Nester, 1990). In fact, inoculation of A. tumefaciens onto K. 
daigremontiana has specifically been used to measure changes in virulence due to 
mutations in the virC operon. A. tumefaciens strains containing mutations leading to loss 
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of function of either VirC1, VirC2, or both proteins showed a severely attenuated 
phenotype. When compared to wild type, mutant strains exhibited a phenotype consisting 
of much smaller tumors on K. daigremontiana leaves (Yanofsky and Nester, 1986; Klee 
et al., 1983; Lu et al., 2009). 
In this work, K. daigremontiana inoculations were used to in order to examine 
changes in virulence in both C58 ∆Pavc2 and C58∆ virC2 mutant strains. First, bacteria 
to be used for inoculation were grown under either induction or nutrient rich conditions 
as described in chapter II Materials and Methods. Tumors produced by each strain were 
scored on a scale of 0 to 3 with a very large tumor scoring a 3 and no tumor scoring a 0 
and compared (Figure 13).  
Several plant inoculation experiments were performed in order to measure 
virulence. Eight experiments, one using bacteria grown in induction conditions and seven 
in nutrient rich conditions, as described in Chapter II Materials and Methods, with a total 
of 244 inoculations were performed to compare virulence in C58 and C58 ∆Pavc2. Three 
experiments were completed to compare virulence between wild type C58 and C58 
∆virC2, one experiment from bacteria grown under induction conditions and two from 
bacteria grown under nutrient rich conditions, as described in Chapter II Materials and 
Methods, with a total of 64 inoculations. In order to determine whether tumors produced 
from the inoculation of different bacterial strains were significantly different, a 
generalized linear mixed model (GLIMMIX) analysis specific for ordinal variables was 
used as a model for data analysis. 
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3.6.1.1 K. daigremontiana inoculations show virC2 knockout mutant C58 ∆virC2 has 
severely attenuated phenotype 
First, let us examine inoculation experiments comparing virC2 deletion mutant 
C58 ∆virC2 with wild-type strain C58. From all experiments performed with the C58 
∆virC2 strain it was quite clear that virulence in the mutant strain was severely attenuated 
(Figure 14, Table 4). In fact, when bacterial cultures were grown under nutrient rich 
conditions, plants inoculated with C58 ∆virC2 failed to produce any tumors at all. The 
two strain produced significantly differently sized tumors under both induction and 
nutrient rich growth conditions (P < 0.001).  
These results show that removal of the virC2 coding sequence causes severe 
attenuation of pathogenic virulence when compared with wild type. These findings also 
agree with previous studies, all of which observed attenuation upon virC2 loss of function 
(Klee et al., 1983; Yanofsky and Nester, 1986; Lu et al., 2009). 
 
3.6.1.2 Changes in virulence observed in C58 ∆Pavc2 in K. daigremontiana inoculations 
K. daigremontiana inoculations were also used to compare virulence between 
wild type C58 and C58 ∆Pavc2. Though it was found that deletion of the anti-virC2 
promoter and the resultant reduction in avc2 transcript expression level did not cause an 
increase in virC2 transcript expression or protein concentration, virulence levels in the 
mutant strain C58 ∆Pavc2 were still examined. It may be possible that while the 
transcript has no effect on levels of VirC2, anti-virC2 plays some other yet unknown role 
in A. tumefaciens virulence. By looking for changes in virulence when the transcript 
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expression levels of anti-virC2 were reduced, we may find evidence of anti-virC2’s 
possible role in pathogenic virulence. 
Surprisingly, under both induction and nutrient rich growth conditions, C58 
∆Pavc2 was observed to produce tumors that significantly differed in size from C58 wild 
type (P < 0.001) (Figure 15, Table 4). When bacterial cultures were grown under 
induction conditions, only 35.9% of C58 wild type inoculation sites did not produce any 
tumors, while 62.5% of inoculation sites from C58 ∆Pavc2 were observed not to produce 
any tumor. A higher number of observations with no tumors present were also observed 
for C58 ∆Pavc2 compared to wild type C58 when bacteria were grown under nutrient 
rich condition (47.2% for wild type C58 and 58.3 percent for C58 ∆Pavc2). In addition, 
tumors formed from C58 wild type were more likely to have a higher tumor score than 
those produced by C58 ∆Pavc2. This result suggests a difference in virulence between the 
C58 ∆Pavc2 strain compared to C58 wild type.  
One hypothesis for this decrease in virulence in the C58 ∆Pavc2 mutant is 
negative regulation of an alternative virulence gene. Perhaps the avc2 transcript is acting 
to stabilize an alternate transcript involved with virulence as previously hypothesized for 
virC2. When expression level of the avc2 transcript is reduced, abundance of the 
stabilized virulence gene transcript could also be reduced, leading to an overall reduction 
in virulence. Alternatively, deletion of the anti-virC2 promoter region may have 
disrupted transcription of other genes on the Ti plasmid leading to the observed reduction 
in virulence.  
Another factor to consider when examining results from K. daigremontiana 
inoculations is the nature of the experiment. Because tumors are only measured on a 
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qualitative scale based on observation by the eye of the researcher, there is room for 
error. It would be beneficial to conduct additional experiments in order to obtain a 
quantitative measurement of virulence.  
 
3.6.2 Use of AGROBEST experiments to quantify changes in virulence within A. 
tumefaciens mutant strains C58 ∆Pavc2 and C58 ∆virC2 
While K. daigremontiana tumorigenesis assays have commonly been used to 
measure pathogenic virulence of A. tumefaciens, this method does not provide 
quantitative results. In order to obtain a quantitative measurement of virulence, 
AGROBEST experiments were carried out. Using these experiments as described in a 
recent 2014 publication, A. tumefaciens virulence can be quantified through transfer, and 
resultant transient expression of the β-D-glucuronidase (GUS) gene in A. thaliana (Wu et 
al., 2014). Though in this particular study researchers described AGROBEST 
experiments as a way to transiently express genes in A. thaliana seedlings, it makes sense 
that these procedures can also be used to measure the virulence of the infecting bacteria. 
The only variable changed during these experiments was bacterial strain, so any observed 
changes in GUS expression in the A. thaliana seedlings can be attributed to the infecting 
strain of A. tumefaciens.  
For AGROBEST experiments, the plasmid vector pB35S GUS was transformed 
into four strains of A. tumefaciens which could then be used to infect A. thaliana. 
Because pB35S GUS contains the GUS gene flanked by right and left border sequences, 
the GUS gene was able to be transferred to the plant during infection where it would then 
be transiently expressed. Strains of A. tumefaciens transformed with pB35S GUS were 
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C58, C58 ∆Pavc2, C58 ∆virC2, and C58 ∆virG (a previously generated virG knockout 
mutant). These strains were then named C58(pB35S GUS), C58 ∆Pavc2(pB35S GUS), 
C58 ∆virC2(pB35S GUS), and C58 ∆virG(pB35S GUS). C58 wild-type was also used as 
a negative control. These bacterial strains were then used to infect A. thaliana seedlings 
and GUS expression analyzed by measuring fluorescence in a plate reader using MUG or 
staining with X-GLUC. C58(pB35S GUS) was used as a standard (Figure 16). 
 
3.6.2.1 virC2 deletion mutant ∆virC2 shows substantial reduction in virulence compared 
to wild type using AGROBEST protocol 
Virulence among the two negative control strains, C58 and C58 ∆virG(pB35S 
GUS), was significantly different than that of wild type C58(pB35S GUS) (P < 0.05). 
These results were to be expected, a wild type strain of A. tumefaciens without a GUS 
gene should not cause GUS expression in plants. Likewise, a bacterial strain without the 
essential virulence gene activator virG would not be able to infect plants and therefore no 
GUS expression would result. Interestingly, it was also observed that C58 ∆virC2(pB35S 
GUS) had a significantly lowered virulence when compared to wild type (P = 0.0072). 
This finding is consistent with K. daigremontiana inoculation data where C58 ∆virC2 
was consistently shown to produce absent or very small tumors upon inoculation. It is 
clear that the virC2 gene is essential for full virulence (Figure 16). 
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3.6.2.2 anti-virC2 promoter deletion mutant ∆Pavc2 shows no significant change in 
virulence compared to wild type using AGROBEST protocol 
When examining GUS expression in plants infected with strain C58(pB35S GUS) 
and C58 ∆Pavc2(pB35S GUS) no statistically significant difference was observed. While 
the average expression of GUS in plants infected with C58 ∆Pavc2(pB35S GUS) was 
slightly higher when compared to wild type, this was not the case for every experiment. 
In fact, large deviations were observed in results from different experiments. When 
examining data from AGROBEST experiments alone, it is not clear that C58 ∆Pavc2 is 
any more or less virulent than C58 wild type.  
Interestingly these results do not reflect the lower amount of virulence observed in 
C58 ∆Pavc2 compared to C58 wild type which was observed from Kalanchoe 
daigremontiana inoculations. There are several hypotheses which may explain these 
findings. First, AGROBEST may be better at showing large reductions in virulence rather 
than smaller decreases. The, reduction of virulence in C58 ∆virC2 was more severe than 
the reduction of virulence observed in C58 ∆Pavc2 as seen in K. daigremontiana 
inoculations. Perhaps AGROBEST was not sensitive enough to catch this difference. In 
addition, the variability in GUS expression among transformed cells within each 
individual plantlet may have been greater than the variability due to bacterial strain used 
for infection when virulence levels were close. Photographs of stained plantlets (Figure 
16) showed a large amount of variation in GUS expression within a plant. 
It is also important to consider that A. tumefaciens to infection of A. thaliana 
plants may have less severe disease levels than on K. daigremontiana. virC1 and virC2 
loss of function mutants had attenuated virulence phenotypes to varying degrees 
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depending on the host plant which the bacteria was tested (Close et al., 1987). It is 
possible that C58 ∆Pavc2 produces a reduced virulence phenotype in K. daigremontiana 
but not in A. thaliana. This difference in tumor phenotype depending on the plant 
infected may explain the difference in results between AGROBEST experiments and K. 
daigremontiana tumorigenesis assays. 
Additionally, it could also be possible that AGROBEST experiments measured a 
different aspect of virulence as opposed to K. daigremontiana inoculation experiments. 
AGROBEST experiments measured transient expression of transferred DNA rather than 
stable integration of transferred genes into the genome. It is possible that C58 ∆Pavc2 
was able to transiently express transferred DNA but unable to stably integrate transferred 
DNA into the plant genome.  
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Figure 7. Expression of virC, anti-virC2. Depth of coverage on nucleotide positions 
194307-195820 on the Ti plasmid. Forward and reverse strands of the virC operon region 
are shown. Regions 1 through 3 of anti-virC2 are indicated as R1, R2 and R3..  
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Figure 8. Illustration of 3’ and 5’ sites for anti-virC2 regions 1, 2 and 3. 3’ and 5’ sites identified by RACE (Rapid 
Amplification of cDNA Ends) are shown for each of the three regions of anti-virC2. 
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Figure 9. Illustration of deleted anti-vir2 promoter in A. tumefaciens strain C58 ∆Pavc2. The promoter region of anti-
virC2 was identified using Softberry Bprom bacterial promoter prediction software. Both a -35 box and a -10 box region were 
identified. Using homologous recombination, knockout mutant C58 ∆Pavc2 was generated with the illustrated 46 bp sequence 
deleted.
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Figure 10. Strand-specific qRT-PCR shows transcript abundance in C58 and C58 
∆Pavc2. Strand-specific qRT-PCR was performed to examine transcript abundance in 
promoter deletion mutant C58 ∆Pavc2 compared to C58 wild type. Three experiments 
were performed with a total of eight separate biological repeats. Significant difference 
from wild type (P < 0.01) is denoted with **. Bars represent standard error.   
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Figure 11. qRT-PCR shows anti-virC2 transcript abundance in C58 and C58 
∆Pavc2. Results are shown for qRT-PCR experiments comparing relative abundance of 
anti-virC2 transcript in A. tumefaciens strain C58 ∆Pavc2 to that of wild type across three 
biological replicates. Housekeeping gene rpoD was used as an internal standard. Bars 
represent Standard Error. 
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Figure 12. Examination of FLAG-tagged VirC2 protein levels. Western blots 
comparing protein between C58::VirC2FLAG and C58 ∆Pavc2::VirC2FLAG. A. A 
similar band was observed from FLAG-tagged VirC2 protein in both C58 wild type and 
C58::VirC2FLAG ∆Pavc2::VirC2FLAG. B. Total protein from both bacterial strains was 
run on a gel for visualization. C. Band intensity was examined using ImageJ software. No 
statistical difference was observed in protein level based on the three biological 
replicates.  
100 
 
 
Figure 13. Scale for qualitative scoring of tumors from Kalanchoe daigremontiana 
tumorigenesis assays. Tumors resulting from K. daigremontiana inoculations were 
scored on a scale from 0 to 3 with 0 being no tumor and 3 being a large tumor.
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Figure 14. Data from all Kalanchoe daigremontiana tumorigenesis assays comparing wild type C58 to C58 ∆virC2. Tumors 
resulting from K. daigremontiana tumorigenesis assays were scored from 0 to 3 and data was recorded. Tumors produced from C58 
wild type were compared to C58 ∆virC2 when grown under either induction (A) or nutrient rich (B) conditions. A significant 
difference was detected between tumors generated between C58 wild type and c58 ∆virC2 when grown under induction conditions. (P 
< 0.001). Because no tumors were produced from C58 ∆virC2 under nutrient rich conditions, data did not fit the generalized linear 
mixed model for ordinal variables to compare bacterial strains. For this data set a significant likelihood ratio test was carried out to 
compare the data sets with and without the effects of bacterial strain. Using this method, it was determined that bacterial strain was 
indeed significant (P < 0.001) 
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Figure 15. Data from all Kalanchoe daigremontiana tumorigenesis assays comparing wild type C58 to C58 ∆Pavc2. Tumors 
resulting from K. daigremontiana inoculations were scored from 0 to 3 and data was recorded. Tumors produced from C58 wild type 
were compared to C58 ∆Pavc2 when grown under either induction (A) or nutrient rich conditions (B). A significant difference was 
detected between tumors generated by C58 wild type and C58 ∆Pavc2 when grown under nutrient rich of induction conditions. (P < 
0.001) 
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Figure 16. Levels of GUS expression are shown in A. thaliana plants infected by 
various strains of A. tumefaciens. AGROBEST experiments were performed to 
compare virulence between various strains of A. tumefaciens. Four-day-old seedlings 
were infected with bacterial cultures and grown for an additional two days before media 
was changed and antibiotics added. Plants were harvested the following day and flash 
frozen before being ground and analyzed for GUS expression. Levels of GUS correspond 
to the transient expression of the GUS gene transferred by the bacteria. ** denotes the 
level of GUS is significantly different from that of wild type (P < 0.05). Bars represent 
standard error. 
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Table 1. Summary of 3’ and 5’ ends for anti-virC2 regions 1, 2 and 3 as observed 
using RACE. 
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Table 2. Strand Specific qRT-PCR was performed to examine transcript levels in promoter deletion mutant C58 ∆Pavc2 
compared to C58 wild type. Three experiments were performed with a total of eight separate biological repeats. Levels of anti-virC2 
transcript were reduced by 39% ±6.5% in C58 ∆Pavc2 (P < 0.001).. 
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Table 3. Non-strand specific qRT-PCR was performed on cDNA from wild type 
C58, C58 ∆Pavc2, and C58 ∆virC2 in order to compare transcript levels. One 
experiment was performed with three biological replicates for wild type and C58 ∆Pavc2 
and two biological replicates for C58 ∆virC2. Housekeeping gene rpoD was used as an 
internal standard.  
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Table 4. Data from all Kalanchoe daigremontiana tumorigenicity assays. Tumors resulting from K. daigremontiana inoculations 
were scored from 0 to 3 and data was recorded. Tumors produced from C58 wild type were compared to other strains when grown 
under either nutrient rich of induction conditions. A significant difference was detected between tumors generated between C58 wild 
type and C58 ∆Pavc2 when grown under nutrient rich of induction conditions. (P < 0.001). Tumors produced from wild type C58 
were also statistically different from those produced from C58 ∆virC2 (P < 0.001). Wild-type versus C58 ∆Pavc2 is shown in Figure 
15 while C58 ∆virC2 versus wild-type is shown in figure 14. 
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CHAPTER IV 
DISCUSSION AND CONCSLUSIONS 
The scope of this work was to select and further explore the action of a candidate 
regulatory RNA in A. tumefaciens. Because of A. tumefaciens’ important role in plant 
transformation, a potential regulatory RNA on the Ti plasmid that was opposite to a 
virulence gene was selected. Specifically, the non-coding RNA transcript opposite 
virulence gene virC2 was chosen. Initially, we hypothesized that the avc2 transcript acted 
to regulate the virC2 transcript in cis because of their shared location in the A. 
tumefaciens genome. If this hypothesis was true, it could explain the large difference in 
virC1 and virC2 transcript expression level which had been previously observed (Lee et 
al., 2013). In order to further investigate this hypothesis, mutant strain C58 ∆Pacv2 was 
generated with a deletion in the promoter sequence of anti-virC2. As a result of this 
deletion, expression levels of avc2 transcript were reduced by approximately 39% ±6.5% 
in C58 ∆Pavc2 as observed by strand-specific qRT-PCR. Mutant strain C58 Pavc2 was 
then compared with C58 wild type to examine the effects of reduced avc2 transcript 
expression level. 
The transcript level of several virulence genes including virC2 were measured for 
comparison using qRT-PCR in both wild-type C58 and C58 ∆Pavc2. In addition, the 
amount of VirC2 protein present in each strain was examined through Western blotting. 
In order to detect any additional roles, the avc2 transcript may play in virulence, both 
Kalanchoe daigremontiana inoculation assays and AGROBEST experiments were 
carried out. The importance of the virulence gene virC2 was also confirmed by 
examining the virulence of virC2 knockout mutant C58 ∆virC2. 
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Initially, before other experiments could be performed, the existence of the avc2 
transcript was confirmed using both 3’ and 5’ RACE. By examining the 3’ and 5’ ends 
from each of the three regions of avc2 expression, it was concluded that a clear 5’ start 
site is present at nucleotide 194400. We also confirmed that the avc2 transcript is indeed 
expressed. However, because of the many different 5’ and 3’ sites found for each region 
of the transcript, we could not determine if the transcript was expressed as one or 
multiple units. The expression pattern of the avc2 transcript may even change based on 
environmental conditions, a phenomenon which has been previously observed in bacteria 
(Waters and Storz, 2009). In future experiments, the expression pattern of the avc2 
transcript could be further explored using Northern Blots. 
After it was confirmed that the avc2 transcript was expressed from the region 
opposite virC2, anti-virC2’s function could be further investigated. Because anti-virC2 
was located directly opposite virC2, it was hypothesized that anti-virC2 may be 
regulating the virC2 transcript in cis. This would make sense because of the 
complementarity which the two transcripts shared and may also explain the large 
difference in virC1 and virC2 transcript expression level. If avc2 acted to bind the virC2 
transcript and target it for degradation, levels of virC2 transcript would decrease in 
response to additional avc2, and increase as expression level of avc2 were reduced.  
In order to reduce the abundance of avc2 within the cell and generate a mutant 
strain of A. tumefaciens which could be compared with wild type, the promoter region of 
avc2 was deleted using homologous recombination. Through strand-specific qRT-PCR it 
was found that deletion of the promoter region led to a reduction in anti-virC2 expression 
level by approximately 39% (P < 0.001). This observation was also confirmed using 
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regular, non-strand specific qRT-PCR. When looking at transcript from the virC2/anti-
virC2 region under conditions of growth without induction by AS, only avc2 transcript 
expression level would be observed since virC2 is not expressed without induction by 
AS. Regular qRT-PCR performed on samples grown without induction with AS showed 
a reduction in transcript from the anti-virC2 region by 49% (P = 0.037). 
 The expression level of virC2 transcript was then compared using qRT-PCR. In 
strand specific experiments, it was observed that expression level of the virC2 transcript 
remained unchanged in C58 ∆Pavc2. The amount of virC1 transcript was also measured 
and compared between C58 wild type and C58 ∆Pavc2. No significant change in virC1 
transcript was observed between the two strains. Ultimately, it was concluded based on 
qRT-PCR data that a reduction in anti-virC2 expression does not affect the abundance of 
either virC1 or virC2 transcript.  
In addition to virC2 transcript expression level, VirC2 protein concentration was 
examined and compared between C58 wild type and C58 ∆Pavc2. Though expression 
level of the virC2 transcript showed no change between C58 and C58 ∆Pavc2, transcript 
expression level may not reflect the actual amount of protein present in each strain. In 
order to examine protein, three replicates of Western blot experiments were carried out to 
detect changes in FLAG-tagged VirC2 protein in both C58::C2-FLAG and C58 
∆Pavc2::C2 FLAG. From Western blotting, no change was detected between abundance 
of VirC2 protein in C58 wild type versus C58 ∆Pavc2 backgrounds. From both Western 
blot and qRT-PCR experiments it was concluded that a decrease in expression level of 
the avc2 transcript did not lead to an alteration in levels of virC2 transcript expression 
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level or protein concentration. Based on this evidence, it is unlikely that avc2 plays a role 
in regulation of its predicted target, virC2. 
Just because the avc2 transcript did not seem to play a role in the regulation of the 
virC2 gene does not mean it does not play a role within the A. tumefaciens cell. It is 
possible that the avc2 transcript regulates the transcript of another gene which may be 
involved with virulence. In order to detect any changes in virulence caused by the 
reduction of anti-virC2 in C58 ∆Pavc2, virulence was compared to C58 wild type using 
both Kalanchoe daigremontiana inoculations and AGROBEST experiments. A virC2 
deletion mutant, C58 ∆virC2, was also generated and used in virulence assays. 
When examining data from K. daigremontiana inoculation experiments a 
significant difference was observed in tumors produced from inoculations with C58 wild 
type versus C58 ∆Pavc2 (P < 0.001). Under both nutrient rich and induction growth 
conditions, tumors from C58 wild type produced less tumors with a score of 0 and more 
large tumors with a score of three when compared to C58 ∆Pavc2. Based only on K. 
daigremontiana inoculation results it appears that C58 ∆Pavc2 exhibits some attenuated 
virulence when compared to wild type C58. 
This observed decline in virulence is not evident when examining data from 
AGROBEST experiments. AGROBEST experiments were based on experiments 
performed by another group in 2014 (Wu et al., 2014). Briefly, strains of A. tumefaciens 
are transformed with plasmid pB35S GUS after which the bacteria is used to infect A. 
thaliana plants. The amounts of GUS expression in infected plants corresponds to the 
virulence of the particular A. tumefaciens strain. GUS production in plants infected by 
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C58(pB35S GUS) was not significantly different from those infected with C58 ∆Pavc2 
(pB35S GUS) over the course of four experiments. 
There are several possible explanations for the difference in observed virulence. 
First, AGROBEST experiments and K. daigremontiana inoculations are measuring 
different variables. AGROBEST experiments measure the ability of A. tumefaciens to 
infect and transiently express a gene in Arabidopsis thaliana while K. daigremontiana 
inoculations measure the ability of A. tumefaciens to infect, stably express genes, and 
form tumors. It is possible that avc2 plays a role in stable integration of genes but does 
not affect transient gene expression. It may also be possible that differences between the 
two plant species used for these experiments led to different results. It has been 
previously observed that virulence differs depending on the particular plant species used 
for inoculation (Close et al., 1987). In another possibility, the AGROBEST experiments 
may not have been sensitive enough to detect small changes in virulence while K. 
daigremontiana inoculations could detect even subtle differences.  
When looking at changes in virulence between C58 ∆virC2 and C58 wild type 
there is a more distinct difference. In both AGROBEST experiments and K. 
daigremontiana inoculations, a significant reduction in virulence was observed in C58 
∆virC2 when compared to wild type when comparing K. daigremontiana inoculation 
results for both induction and non-induction conditions. AGROBEST experiments also 
showed a highly significant decrease in levels of GUS when comparing plants infected 
with C58 ∆virC2(pB35S GUS) to those infected with C58(pB35S GUS) (P < .001). This 
finding demonstrates that both experimental methods are able to show a change in 
virulence when the difference in virulence between two A. tumefaciens strains is large. 
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The severe decrease in virulence observed in C58 ∆virC2 also supports previous findings 
of the importance of virC2 to full virulence.  
In future work, additional potential targets of anti-virC2 may be investigated. 
Using the RNA interaction prediction software IntaRNA several potential targets were 
identified (Wright et al., 2014). Searches using IntaRNA listed in Table 5 were performed 
using the entire sequence of the avc2 transcript. Additional searches were performed for 
each individual region and potential targets overlapping those obtained for the entire 
region were denoted with highlighted cells in Table 5. Not surprisingly, virC2 is on the 
top of the list as a potential target, however, based on observations seen in this work, it is 
not regulated by the avc2 transcript. Future qRT-PCR experiments comparing abundance 
of these transcripts between C58 and C58 ∆Pavc2 may be used to explore the possible 
regulatory effects of anti-virC2 on these possible target transcripts. In addition, the 
possibility of a small transcript peptide by anti-virC2 may also be examined. Recently, 
several groups have found there are several open reading frames along the length of anti-
virC2 that could be investigated. 
This work showed evidence that avc2 does not influence the expression level of 
the virC2 transcript or protein concentration as previously hypothesized. However, that is 
not to say avc2 does not play an alternative role in pathogenic virulence. K. 
daigremontiana inoculations show a difference in virulence when the abundance of avc2 
is reduced in C58 ∆Pavc2 when compared to C58 wild type. This work also confirms 
previous findings of the importance of the virC2 gene in virulence through the methods 
of K. daigremontiana inoculations and AGROBEST experiments. In addition, work done 
in this thesis has expanded knowledge of A. tumefaciens and provides evidence for lack 
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of interaction between a specific non-coding RNA and its hypothesized target. While no 
specific function was found for anti-virC2, this work provides an example of the study of 
regulatory RNA and may be useful as a model for other studies. 
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Table 5. IntaRNA was used to predict possible mRNA targets of the entire anti-
virC2 transcript. (Wright et al., 2014) The top 15 targets are listed here. Targets which 
were also predicted by searching with anti-virC2 region 2 sequence are highlighted in 
blue while those also predicted when searching with anti-virC2 region 3 sequence are 
highlighted in purple. One target was also predicted when searching with anti-virC2 
regions 1 and 3 and is highlighted in red.  
p-value  
fdr 
value  
Target Position  Query  Position  Energy Gene Annotation 
0.000 0.000 Atu6179 90 -- 148 acv2 583 -- 641 -89.193 virC2 putative crown gall tumor protein VirC2 
0.001 0.963 Atu1319 27 -- 85 acv2 548 -- 604 -22.531 gatA glutamyl-tRNA amidotransferase subunit A 
0.001 0.963 Atu0050 78 -- 105 acv2 491 -- 517 -21.925 actR two component response regulator 
0.001 0.963 Atu2266 127 -- 149 acv2 537 -- 565 -21.775     
0.001 0.963 Atu2569 102 -- 144 acv2 526 -- 572 -21.084 thiC thiamine biosynthesis protein 
0.002 0.963 Atu0532 81 -- 145 acv2 543 -- 607 -20.367     
0.002 0.963 Atu4031 101 -- 148 acv2 533 -- 572 -20.101   sugar ABC transporter permease 
0.002 0.963 Atu1979 11 -- 96 acv2 524 -- 611 -20.094   
cyclopropane-fatty-acyl-phospholipid 
synthase 
0.002 0.963 Atu1132 97 -- 144 acv2 521 -- 572 -19.838   glutathione S-transferase related protein 
0.003 0.963 Atu1846 69 -- 149 acv2 532 -- 598 -19.488     
0.003 0.963 Atu3684 101 -- 131 acv2 579 -- 607 -19.459   siderophore biosynthesis protein 
0.003 0.963 Atu0545 109 -- 147 acv2 532 -- 565 -19.296 flaA flagella associated protein 
0.003 0.963 Atu1879 77 -- 120 acv2 534 -- 573 -19.254   
ABC transporter substrate binding protein 
(amino acid) 
0.004 0.963 Atu0837 68 -- 111 acv2 499 -- 536 -18.870   transcriptional regulator MarR family 
0.004 0.963 Atu1601 129 -- 146 acv2 11 -- 28 -18.680 hemN 
oxygen-independent coproporphyrinogen III 
oxidase 
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APPENDIX A 
PRIMERS, FRAGMENTS, PLASMIDS AND STRAINS 
Table 6. Primer list. 
Primer 
Name 
Primer Sequence 
Restriction 
Site 
Size of 
amplified 
region 
Comments 
avcR1-UP-
F1 
CTGCAGGCAATGCTCAGCAATCTTTG PstI 
993bp 
Used for PCR 
amplification of 
anti-virC2 
promoter up 
stream flanking 
sequence 
avcR1-UP-
R1 
GTCGACTAGCAATCTGCTCACGTTGG SalI 
avcR1-
DN-F1 
GTCGACAGCACTGCGGAGTGATTGG  SalI 
958bp 
Used for PCR 
amplification of 
anti-virC2 
promoter down 
stream flanking 
sequence 
avcR1-UP-
R1 
TCTAGACTGAGCGAGAACTTGGCAAT XbaI 
vc2DR-F AGCTGCCTTTCCTCGGTACT None 
N/A 
Used to PCR 
check deletion of 
anti-virC2 
promoter region 
vc2DR-R GTACCGAGGAAAGGCAGCTT None 
VC2-seq-F TGAGGTGAAACTCACGGCAG None 
495bp 
Used for 
sequencing 
∆Pavc2 deletion 
mutant 
VC2-seq-
R 
TCGCTAATAGAAGCCGCTCG None 
VC2KO-
UP-F1 
CTGCAGGCAATGCTCAGCAATCTTTG PstI 
993bp 
Used for PCR 
amplification of 
virC2 up stream 
flanking 
sequence 
VC2KO-
UP-R1 
 GGTACCTAGCAATCTGCTCACGTTGG KpnI 
VC2KO-
DN-F1 
 GGTACCCTTCACCCCTCCAAGGCTT KpnI 
1011 
Used for PCR 
amplification of 
virC2 down 
stream flanking 
sequence 
VC2KO-
DN-R1 
TCTAGACACTTGAGGTGGGCCTACTG XbaI 
VirC2F TGCGGCTCCGAAGAGTTATG None 
N/A 
Used to PCR 
check deletion of 
virC2 region 
VirC2R CGAGCGGCTTCTATTAGCGA None 
vc2T-seq-
F 
GCTGACGTGGATGTTTCGTA None 
829bp 
Used for 
sequencing 
∆virC2 deletion 
mutant 
vc2T-seq-
R 
CTCCTCGAACGGAATCTCAG None 
xx-01 GCTGAAGTCCAGCTGCCAGAAAC None 
498bp 
Used to amplify 
the BAR gene 
and screen for 
the presence of 
pB35S-GUS 
xx-02 ACCATGAGCCCAGAACGACG None 
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virC1-
Flag-F1 
TGGACTACAAAGACCATGACG None 
196bp 
Used to screen 
for N-terminal 
VirC1 FLAG-tag 
virC1-
Flag-R1 
AGTGGTCGGTTTTCATCAGC None 
virC2-
Flag-F1 
CTCCTCGAACGGAATCTCAG None 
154bp 
Used to screen 
for N-terminal 
VirC2 FLAG-tag 
virC2-
Flag-R1 
CCCTTGTCATCGTCATCCTT None 
SO501 CGACTCACTATAGGGAGAGCGGC None   Used for 
sequencing 
vector pJET1.2 
(from 
ThermoFisher 
Scientific, USA) 
SO511 AAGAACATCGATTTTCCATGGCAG None   
5' RACE 
adapter 
ATATGCGCGAATTCCTGTAGAACGAACACTAGAAGAAA None N/A 
5' Adapter used 
during 5' RACE 
(Vogel et al., 
2005) 
B6 GCGCGAATTCCTGTAGA None N/A 5' Adapter 
Specific Primer 
used in 3' RACE 
(Vogel et al., 
2005) 
A3 CGAATTCCTGTAGAACGAACA None N/A 
3' RACE 
adapter 
TTCACTGTTCTTAGCGGCCGCATGCTC None N/A 
3' Adapter used 
during 3' RACE 
(Vogel et al., 
2005) 
E1 GTTCTTAGCGGCCGCATG None N/A 
3' Adapter 
Specific Primer 
used during 3' 
RACE (Vogel et 
al., 2005) 
avcR1-
RACE-R1 
GGGAGAAGGCAACGAACAG None Variable 
Gene Specific 
Primers for 5' 
RACE done on 
anti-virC2 region 
1 
avcR1-
RACE-R2 
CAACGAACAGCTGATCTCTCA None Variable 
avcR1-
RACE-R3 
TCAAAAGATAGGACCCATCCA None Variable 
avcR1-
RACE-R4 
AGGACCCATCCAATCACTCC None Variable 
avcR1-
RACE-F1 
GGAGTGATTGGATGGGTCCT None Variable 
Gene Specific 
Primers for 3' 
RACE done on 
anti-virC2 region 
1 
avcR1-
RACE-F2 
TGGATGGGTCCTATCTTTTGA None Variable 
avcR1-
RACE-F3 
CAGCTGTTCGTTGCCTTCTC None Variable 
avcR1-
RACE-F4 
TCTCCCGAGCAAAGAAACAT None Variable 
avcR2-
RACE-
R12   
TAATAGAAGCCGCTCGCAAT None Variable 
Gene Specific 
Primers Used for 
5' RACE done 
on anti-virC2 avcR2- TCCCGGTCTCGCTAATAGAA None Variable 
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RACE-
R11   
region 2 
avcR2-
RACE-
R10   
GTTCAGACCTCCCGCATGT None Variable 
avcR2-
RACE-R9    
CGATCCCTCACACAGCTTTC None Variable 
avcR2-
RACE-R8    
TCCGAAGAGTTATCCGATCC None Variable 
avcR2-
RACE-R7   
 CGGATGGATCGTTTCGTG None Variable 
avcR2-
RACE-R6    
GCGATTTTGAAAACATGCTG None Variable 
avcR2-
RACE-R5    
CCTTCCAAGTCGCTACAAATG None Variable 
avcR2-
RACE-R4 
TGACAACCTGATCCTGCAAT None Variable 
avcR2-
RACE-R3    
GCGCCTGAAGTATCGAAGAT None Variable 
avcR2-
RACE-R2    
CGCCAGAAAAGATCCAGGT None Variable 
avcR2-
RACE-R1    
GACCGTGGATGCTTTGAGTT None Variable 
avcR2-
RACE-F1    
ATTGCGAGCGGCTTCTATTA None Variable 
avcR2-
RACE-F2 
TTAGCGAGACCGGGAACAT None Variable 
Gene specific 
Primers Used for 
3' RACE done 
on anti-virC2 
region 2 
avcR2-
RACE-F3 
GGGAGGTCTGAACGATGATT None Variable 
avcR2-
RACE-F4 
GAAAGCTGTGTGAGGGATCG None Variable 
avcR2-
RACE-F5 
GCACGAAACGATCCATCC None Variable 
avcR2-
RACE-F6 
CCAGCATGTTTTCAAAATCG None Variable 
avcR2-
RACE-F7 
GGCGCAAGATCATTTGTAGC None Variable 
avcR2-
RACE-F8 
GGACTGTATTGCAGGATCAGG None Variable 
avcR2-
RACE-F9 
GGATCAGGTTGTCATATATCTTCG None Variable 
avcR2-
RACE-
F10 
GCTGAAAGGAAGACCTGGAT None Variable 
avcR2-
RACE-
F11 
GGATCTTTTCTGGCGCTGT None Variable 
avcR2-
RACE-
F12 
CTGTCGTCGAACTCAAAGCA None Variable 
avcR2-
RACE-
ACTCAAAGCATCCACGGTCA None Variable 
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F13 
avcR2-
RACE-
F14 
TGATCAGAGCTGTGACAACG None Variable 
avcR2-
RACE-
F15 
AGGTCGTCGATCTTCCTCGT None Variable 
avcR3-
RACE-R1   
 CGAAATCGTCCATCCTTCTT None Variable 
Gene Specific 
Primers Used for 
5' RACE done 
on anti-virC2 
region 3 
avcR3-
RACE-R2    
TCCATCCTTCTTTGCCTGTT None Variable 
avcR3-
RACE-F1 
AACAGGCAAAGAAGGATGGA None Variable Gene Specific 
Primers Used for 
3' RACE done 
on anti-virC2 
region 3 
avcR3-
RACE-F2 
GGACGATTTCGGGTCGAG None Variable 
avcR3-
RACE-F3 
CTCCCCGACAGACAAAGC None Variable 
VirB1 F TGACAATACCACCGGCGAAA None 
143bp 
qRT-PCR 
Primers for virB1 VirB1 R TCAGACCGAGCACGGAAAAA None 
VirC2 F TGCGGCTCCGAAGAGTTATC None 
102bp 
qRT-PCR 
Primers for 
virC2 
VirC2 R CGAGCGGCTTCTATTAGCGA None 
VirD1 F TCGTCATAGGATGGAGGCCA None 
133bp 
qRT-PCR 
Primers for 
virD1 
VirD1 R ACCGAAGGCGATACGTTCAG None 
VirG F TACGCGAGGAGGAGGTGTAT None 
139bp 
qRT-PCR 
Primers for virG VirG R TCCACGTCAGCGTCAAAGAA None 
rpoD F GCCAGGAGCAGCGTCGTTACAAG None 
123bp  
qRT-Primers for 
rpoD rpoD R CGCCATAGGATTCGGCAAG None 
virC1 F1 GAGCGAACTCAACAACACGA None 
250bp 
qRT-PCR 
Primers for 
virC1 
VirC1 R1 CTCGTGCATGGGAGACTGTA None 
anti-virC2-
R1 
ATTGCGAGCGGCTTCTATTA None 
231bp 
qRT-PCR 
Primers for anti-
virC2 
anti-virC2-
R2 
GCGCCTGAAGTATCGAAGAT None 
avcR1-
OE-F1    
AAGCTTAAAAACTCAGCACTGCGGAG HindIII 
119bp 
Primers used to 
amplify anti-
virC2 region 1 
for pKL1001 
avcR1-
OE-R1   
CCGCGGAGCTGGCTACCGCAGCG SacII 
avcR2-
OE-F1    
AAGCTTAATCTCGACGAGGAAGATCG HindIII 
412bp 
Primers used to 
amplify anti-
virC2 region 2 
for pKL1002 
avcR2-
OE-R1    
CCGCGGCCAATCCCAATGGATCAAAG SacII 
avcR3-
OE-F1    
AAGCTTCAAACCCGCTTTGTCTGTC HindIII 
103bp 
Primers used to 
amplify anti-
virC2 region 3 
for pKL1003 
avcR3-
OE-R1    
CCGCGGCGGCAGGGTCGAGTTTT SacII 
virGC-
IGR-F1   
AAGCTTCGAACAGCTGATCTCTCAAAAG HindIII 158bp 
Primers used to 
amplify 
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virGC-
IGR-R1   
CCGCGGGCCTGAGGTAGAGGTGCATT SacII 
virC/virG 
intergenic region 
for pKL1004 
pTF505F1 GCCTCTTATCCATTCTCATTGAA None 
Variable 
Primers for 
sequencing 
inserts in 
pTF505 
pTF505F2 ACGGCTGCACTGAACGTC None 
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Table 7.Fragments list. 
Fragment 
Name 
Fragment Sequence 
Restriction 
Site 
Size  Comments 
3xFLAG_vir
C1 
ATCCaagcttAAGAAAGCCACCAATGCGGCGCACCGCAACCCGTAT
GGCCATGCTGTCGGAGAGGCCCAGCAAGCGTGCCTGATGAGAA
AAACTCTCATATTCGGCCGATCTTAATCGGGTACTGACGACCTTG
AAGCCTTCAACCTTCACGCATTCGCGCTGGTTGACGGCAATGTCA
CTTGAGGTGGGCCTACTGCCTTGCGACATAGCTTCCTCCATAGAA
GACGGAAAGATCTGAACTTGCCCCGCCGTAGCATTTCCTCGTCGT
GGCAGATGGGAATCTAGCCATATACAAAACGAAATCAAGAACAC
ATAAGGGATATTTATTTTTATATTATTACAATTGAAATTATATTAC
AATAAAATTGAAATATAAAATCAGGTAATTACTACATTACTTATG
AATTATCGCAAAATCATACACACAAATAAAAGTACAGACACACTT
CCGCTTCACAAAATCGACAGGATAAGGACATGGACTACAAAGAC
CATGACGGTGATTATAAAGATCATGATATCGATTACAAGGATGA
CGATGACAAGAAACTTCTGACATTTTGCTCCTTCAAGGGAGGAG
CCGGCAAAACCACGGCACTCATGGGTCTTTGCGCCGCCTTTGCAA
GTGACGGCAAACGATTGGCTCTCTTCGACGCTGATGAAAACCGA
CCACTAACGCGATGGAAAGAAAACGCCCTTCGCAGCAATACCTG
GGGCTCCTTCTGCGAAGTCTACGCCGCCGAGGAAATGGCACTCC
TTGAGGCGGCCTATGAGGACGCCGAACTCCAGGGATTTGATTAT
GCGCTGGCCGATACGCATGGTGGTTCGAGCGAACTCAACAACAC
GATCATTGCCAGCTCAAACCTGCTTCTGATCCCGACCATGTTAAC
TCCGCTCGATATCGATGAAGCATTGTCGACCTACCGCTATGTCAT
TGAACTGCTGCTGAGCGAGAACTTGGCAATTCCGACAGCCGTAT
TGCGCCAACGCGTGCCGGTTGGTCGATTGACCACATCGCAGCGC
GCGATGTCGGACATGCTCGCAAGCCTTCCAGTTGTACAGTCTCCC
ATGCACGAGAGAGACGCATTTGCCGCGATGAAGGAACGTGGCA
TGTTGCATCTCACATTGCTGAATATGAGAACCGATCCGACAATGC
GCCTCCTCGAACGGAATCTCAGAATCGCCATGGAGGAACTCGTC
ACTATCTCCAAATTGGTTAGCGAAGCCTTGGAGGGGTGAggatcc
CGTA 
Hind 
III/BamHI 1250 
Fragment used to 
generate N-terminal 
VirC1 FLAG tagged 
sequence 
3xFLAG_vir
C2 
ATCCaagcttTACCTGGGGCTCCTTCTGCGAAGTCTACGCCGCCGA
GGAAATGGCACTCCTTGAGGCGGCCTATGAGGACGCCGAACTCC
AGGGATTTGATTATGCGCTGGCCGATACGCATGGTGGTTCGAGC
GAACTCAACAACACGATCATTGCCAGCTCAAACCTGCTTCTGATC
CCGACCATGTTAACTCCGCTCGATATCGATGAAGCATTGTCGACC
TACCGCTATGTCATTGAACTGCTGCTGAGCGAGAACTTGGCAATT
CCGACAGCCGTATTGCGCCAACGCGTGCCGGTTGGTCGATTGAC
CACATCGCAGCGCGCGATGTCGGACATGCTCGCAAGCCTTCCAG
TTGTACAGTCTCCCATGCACGAGAGAGACGCATTTGCCGCGATG
AAGGAACGTGGCATGTTGCATCTCACATTGCTGAATATGAGAAC
CGATCCGACAATGCGCCTCCTCGAACGGAATCTCAGAATCGCCAT
GGAGGAACTCGTCACTATCTCCAAATTGGTTAGCGAAGCCTTGG
AGGGGTGAAGATGGACTACAAAGACCATGACGGTGATTATAAA
GATCATGATATCGATTACAAGGATGACGATGACAAGGGAATTCG
CAAACCCGCTTTGTCTGTCGGGGAGGCCAGGCGGCTTGCCGCCG
CTCGACCCGAAATCGTCCATCCTTCTTTGCCTGTTGCCACCCAAAA
Hind 
III/BamHI 1229 
Fragment used to 
generate N-terminal 
VirC2 FLAG tagged 
sequence 
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CTCGACCCTGCCGCAGCCGCCTGAAAATCTCGACGAGGAAGATC
GACGACCTGCCCCAGCCACCGCCAAGCGTTGTCACAGCTCTGATC
AGCAATCGATGCTGACCGTGGATGCTTTGAGTTCGACGACAGCG
CCAGAAAAGATCCAGGTCTTCCTTTCAGCGCGCCCGCCCGCGCCT
GAAGTATCGAAGATATATGACAACCTGATCCTGCAATACAGTCCT
TCCAAGTCGCTACAAATGATCTTGCGCCGTGCGCTTGGCGATTTT
GAAAACATGCTGGCGGATGGATCGTTTCGTGCGGCTCCGAAGAG
TTATCCGATCCCTCACACAGCTTTCGAAAAATCAATCATCGTTCAG
ACCTCCCGCATGTTCCCGGTCTCGCTAATAGAAGCCGCTCGCAAT
CACTTTGATCCATTGGGATTGGAGACCGCCCGGGCTTTCGGCCAC
AAGCTGGCTACCGCAGCGCTTGCATGTTTCTTTGCTCGGGAGAA
GGCAACGAACAGCTGAggatccCGTA 
3xFLAG_vir
G 
ATCCtctagaGAAAAGCAGCGCTCAGGGGGCTAGCTTGGAAGATC
GCACCCTGATTGACATGCTCGCAACCGCAGTTGATGTCATCGTAC
CCTTCCGTGCCCACGGTGACATTTACGAGGTGGGCGAAATCTGG
CTCGCTGCCGATGCGCGTCGGCGCGGTGAGACAATAGGCGATCT
TCTTAACCAGCAGTAGTTGTGATCCATGTTTCTAAATGCCGCATG
GCGCGTTGTAGAATTACGTTTGTAGCAATGCTCAGCAATCTTTGT
CATCAAACGGAGACATCTAGTTTGCATTTCTGTCGTGCGCGGTTT
GGTCGAAATCTTGCCGAAATGCCCGTGTAGTGAGAGAAAATTAA
AGAGTGGAGTCTAGCAAATACAACCTTTACGTGTATAAATTCTGT
TGAGCTGCAAATGGACTACAAAGACCATGACGGTGATTATAAAG
ATCATGATATCGATTACAAGGATGACGATGACAAGGCTGGCCAG
GATCCTAGATTGAGAGGTGAACCGTTGAAACACGTTCTTGTCATC
GATGACGATGTCGCTATGCGGCATCTTATAGTCGAGTATCTTACG
ATCCATGCCTTTAAGGTGACTGCGGTAGCCGACAGCAAGCAGTT
CAATCGTGTACTCTGCTCCGAGACGGTCGATGTCGTGGTCGTCG
ATCTTAATTTGGGTCGCGAAGATGGGCTTGAAATTGTTCGTAGTC
TGGCCACGAAGTCCGATGTTCCAATCATAATTATTAGCGGCGCTC
GCCTCGAAGAGGCGGACAAAGTTATTGCGCTCGAGTTGGGAGC
AACCGATTTTATTGCCAAGCCTTTTGGGACGCGGGAATTTCTGGC
GCGCATCCGTGTTGCGTTACGCGTGCGGCCCAGTGTCGCGCGAA
CCAAAGATCGACGCTCATTTAGTTTCGCTGACTGGACACTTAATC
TCAGGCGACGCCGCTTGATTTCGGAAGAGGGCAGTGAGGTGAA
ACTCACGGCAGGTGAGTTTAATCTCCTGGTTGCTTTCCTGGAGAA
GCCGCGCGACGTCCTATCCCGGGAGCAGCTTCTGATCGCCAGTC
GGGTACGCGAGGAGGAGGTGTATGACAGAAGTATTGATGTCCT
CATTTTGCGGCTGCGCCGGAAGCTTGAGGGGGATCCGACGACCC
CTCAGTTGATCAAGACTGCAAGAGGTGCTGGCTATTTCTTTGACG
CTGACGTGGATGTTTCGTACGGGGGTGTGATGGCGGCCTGActgc
agCGTA XbaI/PstI 1250 
Fragment used to 
generate N-terminally 
FLAG tagged VirG 
sequence 
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Table 8. Plasmid list 
Plasmid  Description/Use Reference 
pTFsacB 
Vector for homolgous 
recombination, 5724 bp, 
Kanamycin resistance 
Dr. Kan Wang Lab collections, 
designed by Dr. Keunsub Lee, 
(unpublished) 
pJET1.2 
Sequencing Vector, 2974bp, 
Carbenicillin resistance 
CloneJET PCR cloning kit 
(ThermoFisher Scientific, USA) 
pAJ007 
Used to generate anti-virC2 
promoter knockout mutant 
∆Pavc2, 7652bp, Kanamycin 
resistance 
This Work 
pAJ008 
Intermediate Sequencing Vector 
for pAJ007 Contains Up stream 
flanking sequence, 3586 bp, 
Carbenicillin resistance 
This Work 
pAJ009 
Intermediate Sequencing Vector 
for pAJ007, Contains Down-
stream Flanking Sequence, 3551 
bp, Carbenicillin resistance 
This Work 
pAJ019 
Intermediate Sequencing Vector 
for pAJ021, Contains up stream 
Flanking Sequence, 3604 bp, 
Carbenicillin 
This Work 
pAJ020 
Intermediate Sequencing Vector 
for pAJ021, Contains 
downstream Flanking Sequence 
, 3586 bp, Carbenicillin 
resistance 
This Work 
pAJ021 
Used to generate virC2 
Knockout mutant ∆virC2, 7705 
bp, Kanamycin resistance 
This Work 
pTF505 
Overexpression vector, 6789 bp, 
Spectinomycin resistance 
Dr. Kan Wang Lab collections, 
Designed by Dr. Keunsub Lee, 
(Lee et al., 2013) 
pKL1001 
Overexpression of anti-virC2 
region, 16885 bp, 
Spectinomycin resistance 
This Work 
pKL1002 
Overexpression of anti-virC2 
region 2, 7177 bp, 
Spectinomycin resistance 
This Work 
pKL1003 
Overexpression of anti-virC2 
region 3, 6881 bp, 
Spectinomycin resistance 
This Work 
125 
 
pKL1004 
Overexpression of virC2/virG 
intergenic region, 6936 bp, 
Spectinomycin resistance 
This work 
pKL1006 
Used to generate VirC2 FLAG-
tagged mutant strains, 6905 bp, 
Kanamycin resistance 
This work 
pKL1007 
Used to generate VirC1 FLAG-
tagged mutant strains, 6926 bp, 
Kanamycin resistance  
This work 
pKL1015 
Used to generate VirG FLAG 
tagged mutant strains, 6926 bp, 
Kanamycin resistance 
This work 
pB35S-GUS 
Used for the expression of GUS 
during AGROBEST 
experiments, 11276 bp, 
Kanamcin resistance 
Dr. Kan Wang Lab Collections 
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Table 9. A. tumefaciens strain list 
Strain Description Reference 
C58 C58 Wild-Type Dr. Kan Wang Lab Stock 
C58 ∆Pavc2 
Deletion mutant of anti-virC2 
promoter region This Work 
C58 ∆virC2 Deletion mutant of virC2 gene This Work 
C58 ::VirC2-FLAG FLAG-tagged VirC2 This Work 
C58 ::VirC1-FLAG FLAG-tagged VirC1 This Work 
C58::VirG-FLAG FLAG-tagged VirG This Work 
C58 ∆Pavc2 ::VirC2-FLAG FLAG-tagged VirC2 This Work 
C58 ∆Pavc2 ::VirC2 FLAG FLAG-tagged VirC1 This Work 
C58 ∆Pavc2::VirG-FLAG FLAG-tagged VirG This Work 
C58 ∆virC2 ::VirC1-FLAG FLAG-tagged VirC1 This Work 
C58 ∆virC2::VirG-FLAG FLAG-tagged VirG This Work 
 
  
127 
 
APPENDIX B  
SUPPLEMENTAL INFORMATION 
 
Introduction 
While the majority of work performed for this research project is contained in the 
main body of the thesis, some additional work is described here in Appendix B, 
Supplemental Information. Projects contained here were either not relevant to the 
narrative of the avc2 transcript and its function or did not produce reportable results 
because of technical errors.  
Research is a learning process. By describing all experiments performed whether 
or not they were successful I am able to better reflect on past mistakes and review what 
could have been done differently. By including this supplemental work, I hope to 
demonstrate additional undertakings which have been performed, as well as ways in 
which I have learned and am able to better plan for the future.  
Organization of this supplemental information is divided into sections, each of 
which describes a different project not included in the main body of the thesis. An 
overview of each project is included, as well as ways which the project may be improved 
and used in future research is applicable. Figures and tables included here are referenced 
as Figure S1, Figure S2, and so on, while figures from the main thesis are simply Figure 1 
and Figure 2. 
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Overexpression of Individual anti-virC2 Regions and Intergenic Region 
As previously described in the main body of the thesis, the avc2 transcript can be 
divided into 3 (possibly 4) regions based on expression pattern (Figure 7). In order to 
better understand the function of each individual region, constructs overexpressing each 
of these regions were generated and transformed into A. tumefaciens strains C58 and C58 
∆Pavc2. In addition to the regions of avc2 which were overexpressed, the intergenic 
region between the virC and virG operons was overexpressed in a similar way. An 
illustration depicting overexpressed transcripts and constructs generated can be found in 
Figure S1. 
 
Construction of overexpression plasmids pKL1001- pKL1004 
Four constructs were generated to overexpress each region of the avc2 transcript 
as well as the intergenic region between the virG and virC operons. Regions to be 
overexpressed were selected based on previous sequencing data generated by Lee et al. 
(2013) and are illustrated in Figure S1. 
First, primer pairs were designed to amplify each of the desired genetic sequences 
from A. tumefaciens total DNA using PCR. Each primer pair was designed to include 
HindIII/SacII restriction sites for cloning. Once fragments had been amplified they were 
first cloned into sequencing vector pJET1.2 for sequencing to check for any possible 
mutations. After the initial sequencing check, fragments were then digested out of 
pJET1.2 and cloned into vector pTF505. Vector pTF505 is an overexpression vector 
which contains the constitutive promoter PrrnC from Sinorhizobium meliloti, followed by 
a multiple cloning site, and transcriptional terminator, TpsbANT. A total of four plasmids 
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were generated and named pKL1001, pKL1002, pKL1003, and pKL1004 to overexpress 
desired transcript regions as shown in Figure S1.  
Each of the four overexpression vectors was transformed into both wild type C58 
and C58 ∆Pavc2. These bacteria strains were then termed C58(pKL1001-1004) and C58 
∆Pavc2(1001-1004). All cloning and design steps were performed by Dr. Keunsub Lee 
with assistance from myself. 
 
Vir gene expression in C58 ∆Pavc2 overexpression strains 
After overexpression mutants were generated, select transcript levels were then 
able to be measured using qRT-PCR. Initially, only strains C58 ∆Pavc2(pKL1001-1004) 
were analyzed. This was done to minimize the amount of bacterial cultures handled at 
one time and avoid human errors which may occur when dealing with an abundance of 
samples at one time. qRT-PCR was performed using random hexamers to synthesize 
cDNA as described in Chapter II Materials and Methods. Since only two replicates of 
qRT-PCR were performed, proper statistical analysis was not carried out. However, 
observations from the data can still be made. Results for qRT-PCR experiments are 
shown in Figure S2 as well as Table S1.  
When examining transcript levels in overexpression mutants C58 
∆Pavc2(pKL1001-1004) there are several observations which can be made. First it can be 
observed by examining virC2 levels in C58 ∆Pavc2(pKL1002) that the intended region is 
indeed being overexpressed. Because virC2 primers used were specific to the region 
overexpressed by the pKL1002 vector, overexpression of that transcript is able to be 
observed. This also confirms that the overexpression vector is functioning properly at 
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least for pKL1002. However, in future studies, primers could be designed specifically to 
each section in order to confirm the functionality of each individual vector. 
Also, it appears that virG transcript levels are elevated in every A. tumefaciens 
strain which contains a deletion of the avc2 promoter region. This result was previously 
observed when regular qRT-PCR was performed on C58 and C58 ∆Pavc2 as detailed in 
Chapter III Results. Interestingly, there appears to be elevated expression levels of virG 
even when the deleted avc2 promoter region or any other region of the avc2 transcript is 
overexpressed. This demonstrates a failure of any of the pKL1001 through pKL1004 
vectors to complement C58 ∆Pavc2 and return levels of virG transcript to a similar level 
as those in wild type C58. This means that the change in nucleotide sequence directly 
downstream of the virG operon and not lack of avc2 transcript is the cause of this higher 
observed level of virG. In future studies, homologous recombination could be used to 
replace the deleted sequence in C58 ∆Pavc2. Then, virG expression levels could be 
examined and compared to wild type to check for complementation. 
It is also important to notice the inconsistency of the qRT-PCR data shown here. 
While transcript levels were compared to that of wild type to generate the graph shown in 
Figure S2, real numbers are listed in Table S1. By looking at relative transcript 
abundance as shown in Table S1 it can be seen that the abundance of transcripts between 
experiments was not at all consistent. Most likely, this inconsistency was caused 
problems with RNA extraction and handling when I was the one performing the 
extraction. Many repeated attempts were made which resulted in completely degraded 
RNA samples which could not be used for cDNA synthesis and when RNA was extracted 
and cDNA synthesized, results were not consistent. In future studies, an alternate 
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researcher may be able to perform additional qRT-PCR in order to more fully examine 
the effect of overexpression of various regions of the avc2 transcript. 
 
pAJ025; Constitutive Expression of virC2 and Inducible Expression of anti-virC2 
As stated earlier, it was initially hypothesized that the avc2 transcript somehow 
acted to regulate its potential target and cis-encoded gene virC2. While we can now see 
that there is a lack of evidence to link the two, at the beginning of this research a 
connection was hypothesized.  
 
A vector is designed to test regulation of virC2 by anti-virC2 
In order to test for the possible regulation of avc2 on virC2, a special vector 
named pAJ025 was designed (Figure S3). On this vector, which was synthesized at 
Genscript using pTF505 as starting material, virC2 is expressed using the constitutive 
promoter Prrnc while avc2 is inducibly expressed by the virB promoter. The process of 
pAJ025 design and ordering was assisted by Dr. Keunsub Lee and Dr. Jennifer Raji. 
Once received from Genscript, the vector was first transformed into A. tumefaciens C58 
wild type to check for proper expression. 
 
pAJ025 does not properly express virC2 and anti-virC2 transcripts  
Regular qRT-PCR was performed to examine expression levels in C58(pAJ025). 
Four biological replicates of qRT-PCR were performed in order to examine levels of 
transcript from the virC2/anti-virC2 region (Figure S4). It is important to remember that 
because these two genetic sequences are complementary, they will both be detected as 
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one when performing non-strand specific qRT-PCR. Because the pAJ025 vector is 
constructed to constitutively overexpress virC2 and inducibly express avc2, transcript 
levels were expected to be greatly elevated in qRT-PCR experiments. Unfortunately, this 
was not the case. Based on the four replicates of qRT-PCR, no statistical difference was 
detected between C58 transformed with pAJ025 compared to C58 transformed with the 
empty backbone vector pTF505. When bacteria were grown under induction conditions, 
levels of virC2/avc2 transcript were slightly elevated in C58(pAJ025) when compared to 
C58(pTF505) but not enough to be considered statistically significant (Figure S4). Under 
non-induction conditions there was barely any difference in transcript expression level 
between C58(pAJ025) and C58(pTF505). Based on these results, it appears there is 
something wrong with the pAJ025 vector. 
One possible explanation for the lack of virC2 and avc2 expression observed in 
C58(pAJ025) comes from the design of the vector itself. Because both avc2 and virC2 
sequences are encoded in pAJ025, the vector has two large regions which are 
complementary to one another. It could be possible that the vector is base-pairing with 
itself while in the bacterial cell, which is leading to its lack of function. Because of the 
evidence already produced showing a lack of interaction between the avc2 and virC2 
transcript, this project was put aside. This may be one part of the project which is not 
worth picking up again in the future  
 
Additional FLAG-Tagged Proteins 
As described in the main body of this thesis, A. tumefaciens strains were 
generated in which an N-terminal FLAG tag was inserted into the genomic sequence of 
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the virC2 gene. In addition, A. tumefaciens strains were generated in a similar manner 
which contained an N-terminal FLAG tag in the coding sequence of either the virC1 or 
virG gene. Because VirG-FLAG and VirC1-FLAG proteins were unable to be visualized 
during Western blot, their construction and attempted visualization with Western blot will 
be described here in the supplemental chapters. 
 
Construction of A. tumefaciens strains containing VirC1-FLAG and VirG-FLAG tagged 
proteins 
The method of homologous recombination (Ried and Collmer. 1987) was used to 
generate mutant A. tumefaciens strains which contained an N-terminal FLAG-tag in the 
coding sequence of either the virC1 or virG genes. First, oligo fragments were ordered 
from IDT which contained a sequence including upstream and downstream regions 
surrounding the FLAG-tag to be inserted. Restriction sites were also added for cloning. 
Fragments 3xFLAG-virG and 3xFLAG-virC1 were digested with appropriate restriction 
enzymes and then cloned into vector pTFsacB to generate pKL1015 and pKL1006 
respectively. Construction details for all vectors used to generate FLAG-tagged proteins 
are shown in Figure S5.  
After construction of vectors pKL1006 and pKL1015 were complete, vectors 
were transformed into A. tumefaciens strains C58 wild type and C58 ∆Pavc2 to generate 
strains C58::virC1-FLAG, C58::virG-FLAG, C58 ∆Pavc2::virC1-FLAG, and C58 
∆Pavc2::virG-FLAG. Selection for homologous recombination was then performed as 
described in Chapter 2 Materials and Methods and illustrated in Figure 3. Breifly, LB 
containing kanamycin was used to screen for an initial recombination event. A second 
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recombination event was found for by screening for the ability of bacteria to grow on LB 
media containing sucrose. The presence of a FLAG-tag was further confirmed by PCR. 
 
VirC1-FLAG and VirG-FLAG proteins fail to visualize during Western blot 
Western blot was then performed on A. tumefaciens strains to compare VirC1-
FLAG and VirG-FLAG tagged proteins between C58 wild type and C58 ∆Pavc2 as 
described in Chapter 2 Materials and Methods.  
Bacterial protein extracts containing VirC1-tagged or VirG-tagged proteins failed 
to visualize on film. Samples were run along with VirC2-FLAG tagged protein which 
was able to be used as a positive control. Additionally, the design of sequence of 
fragments ordered from IDT were checked for accuracy and no error was found.  
There are several possible reasons why these proteins were unable to be 
visualized. First, it is possible that VirG-FLAG and VirC1-FLAG proteins were more 
fragile than VirC2-FLAG and were degraded during the extraction process. However, 
unless the FLAG-tag epitope was completely degraded a band would still be expected to 
be seen at an somewhere on the blot, or perhaps as a smear (Mahmood and Yang, 2012). 
It is also possible that the amount of FLAG-tagged protein present in the sample was not 
present in a concentration high enough to be detected (Mahmood and Yang, 2012). The 
problem may also have to do with the 3xFLAG tag interfering with protein expression.  
In order to overcome this problem and visualize VirG and or VirC1 FLAG-tagged 
proteins using Western blot in the future, alternative A. tumefaciens mutants could be 
generated which contain C-terminally tagged proteins instead of the current N-terminal 
tag. This could easily be done by ordering additional fragments through IDT which could 
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then be cloned into vector pTFsacB followed by homologous recombination to generate a 
C-terminal FLAG tag. 
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Figure S1 pKL1004 through pKL 1001 were used to overexpress each of the three 
regions of the anti-virC2 transcript as well as the intergenic region between the virC 
and virG operons. Expression of each region expressed is shown in under induction and 
non-induction conditions. Specific regions expressed in each construct are denoted in 
green arrows and are aligned to their specific place along the A. tumefaciens genome 
sequence
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Figure S2. Vir Gene transcript expression is examined in C58 ∆Pavc2 strains overexpressing a portion of the anti-virC2 
transcript. C58 wild type and C58 ∆Pavc2 both containing empty vectors are used for comparison. Induction conditions were 
used for bacterial growth conditions 
. 
1
3
8
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Figure S3. Vector pAJ025. This vector was designed with the goal of constitutively 
overexpressing the virC2 transcript while inducibly expressing the avc2 transcript. The 
vector backbone comes from the pTF505 which was sent to Genscript where pAJ025 was 
constructed and sent back for transformation into A. tumefaciens. 
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Figure S4. Relative abundance of transcript from the virC2/anti-virC2 region is 
shown for C58(pTF505) (empty vector) and C58(pAJ025). There is no statistical 
difference between transcript levels when comparing C58(pTF505) and C58(pAJ025) 
under either induction or non-induction conditions (P = 0.1333 and 0.9928 respectively 
by paired sample students t-test). 
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Figure S5. Construction of constructs used to generate A. tumefaciens FLAG-tag 
mutants. Mutant strains were generated which contain N-termianally tagged VirC2, 
VirC1 and VirG proteins. While VirC2-FLAG proteins were able to be detected and 
visualized using Western blot, VirC1-FLAG, and VirG-FLAG proteins failed to do so.  
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Table S1. Transcript Abundance is shown for overexpression strains C58 ∆Pavc2(pKL1001-1004) along with to C58 ∆Pavc2 
and C58 wild type empty vector for comparison. 
1
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